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Abstract 
Carl William Kellett 
The role of the SWI/SNF ATP dependent chromatin remodelling complex in 
the regulation of the human hair follicle cell proliferation and control of the 
human cutaneous wound healing  
Keywords: Epigenetics, Chromatin Remodelling, SWI/SNF, Wound healing, 
Hair follicle, Skin, migration, BRG1 
Epigenetic regulation of gene expression occurs at a number of levels 
including covalent DNA and histone modifications, nucleosome positioning 
and ATP-dependent chromatin remodelling as well as higher order chromatin 
folding and 3D genome organisation. ATP-dependent chromatin remodelling 
complexes modulate nucleosome structure, positioning and chromatin de-
compaction and are involved in gene activation and repression. SWI/SNF 
ATP-dependent chromatin remodelling complexes contain either BRG1 or 
BRM as the core ATPase together with other common and variable subunits. 
BRG1 is required for terminal epidermal differentiation in mice and humans 
and for hair follicle stem cell activation during mouse hair follicle regeneration 
and cutaneous wound healing. However, the role of SWI/SNF complexes in 
human hair growth and wound healing remain unknown.  
Here it is demonstrated that genes encoding SWI/SNF complex subunits are 
expressed in human hair follicles. It also highlights that siRNA mediated 
suppression of SWI/SNF complexes in hair follicle culture has no effect on 
 ii 
 
hair growth, or anagen-catagen transition in the short term, but a significant 
increase in proliferation of the outer root sheath keratinocytes was seen. The 
data also documents the expression of several SWI/SNF subunits in human 
epidermis and that siRNA mediated SMARCA4 gene suppression in primary 
human keratinocyte monolayers defined the requirements of BRG1 for 
wound closure through control of cell migration, but not proliferation.  
In summary, this data revealed a diverse SWI/SNF complex subunit 
composition in human epidermis and hair follicle, and an essential role of the 
core complex ATPase BRG1 in keratinocyte migration during wound closure 
and re-epithelisation.   
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1. Introduction 
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Mammalian skin serves as a barrier between an organism and the external 
environment, providing protection from environmental hazards such as UV-radiation, 
micro-organisms, physical trauma and dehydration. The skin also maintains the 
organism internal temperature, furthermore skin serves as a sensory organ 
(D'Orazio et al., 2013, Hanel et al., 2016). 
Skin is a multi-layered structure, consisting of the outermost epidermis, dermis and 
sub-cutis. The epidermis is a dynamic self-renewing tissue, primarily made up of 
keratinocytes as well as melanocytes, Merkel cells and Langerhans cells (Boulais 
and Misery, 2008, Debeer et al., 2013). The epidermis is also involved in the 
formation of several epidermal appendages in the skin, including hair follicles, 
sebaceous and sweat glands and nails (Wang et al., 2016, Lehoczky et al., 2011). 
Mammalian hair follicles are skin appendages which are generated as a result of a 
series of complex ectodermal-mesenchymal interactions (Ahmed et al., 2014, 
Blanpain and Fuchs, 2009). Almost all human and animal hair follicles are generated 
during the embryonic stage of development, although in adult mice de novo hair 
follicle generation has been seen after large wound healing (Gay et al., 2013, 
Rognoni et al., 2016, Zhu et al., 2017). 
Like the skin, hair confers several abilities to the host organism, including assisting 
with thermoregulation, protection from environmental insults, sensory information 
and enhanced wound healing; although some of these abilities are more obvious in 
non-human mammals, the quills of a porcupine, whiskers of a cat, or the horn of a 
rhinoceros for example. The mature hair follicle contains epidermal progenitor and 
stem cells, which serve not only to replenish and regenerate itself during each cycle, 
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but also support re-epithelialisation after the cutaneous wounding (Plikus et al., 
2015).  
Epidermal and hair follicle development and regeneration are controlled by 
molecular networks of cell signalling pathways, transcription factors and epigenetic 
regulators. The key components of these networks were characterised in recent 
decades using genetically modified mice, cultured cells and ex-vivo culture of 
human hair follicles or whole human skin explants (Yang et al., 2014, Philpott et al., 
1996, Nakamura et al., 1990). However, most of our knowledge about epidermal 
and hair follicle biology is based on animal studies; as such it requires further work 
to define their relevance to humans (Shanks et al., 2009, Arends et al., 2016). 
1.1 Epidermal morphogenesis and homeostasis 
The epidermis is a self-renewing epithelial tissue, and while keratinocytes make up 
much of the epidermis there are several additional cell types located within the 
epidermis, including Langerhans cells which serve an anti-microbial role during 
infections, Merkel cells which provide touch/pressure sensory information and 
melanocytes which produce and distribute melanin affecting skin pigmentation and 
providing protection against UV-B damage (Maricich et al., 2009, Hogan and Burks, 
1995, Lewis et al., 2015, Cichorek et al., 2013, Erickson and Echeverri, 2018). 
Epidermal development takes place during embryogenesis; in mice it begins at 
embryonic day (E) 9.5 and progresses in a well-timed and predictable way, resulting 
in a fully formed epidermis by E18.5, while in humans the progression is highly 
similar but with a longer timeframe, beginning during week 8 and having a fully 
formed epidermis by week 22/23 (Coolen et al., 2010, Koster and Roop, 2007, 
Sotiropoulou and Blanpain, 2012). 
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The adult epidermis is maintained via homeostatic regulation, involving basal layer 
progenitor cells, which proliferate and undergo terminal differentiation while moving 
outward in a columnar direction, replenishing the outermost layer (the cornified 
layer) which is constantly sloughed off. 
1.1.1   Epidermal structure and functions 
The epidermis is a collection of stratified cells arranged as layers, each 
demonstrating its own characteristics and functionality. There are four layers in the 
majority of the skin sites; from deepest to outermost they are; or stratum basale (the 
basal layer), the stratum spinosum (the spinous layer), the stratum granulosum (the 
granular layer) and the stratum corneum (the cornified layer), with keratinocytes 
becoming more differentiated as they progress outward from basal to cornified 
layers (Horsburgh et al., 2017). There is an additional layer in the particularly thick 
skinned areas (soles of the feet in humans and foot pads of animals for example) 
known as the stratum lucidum (the clear layer) which sits between the spinous and 
granular layer and serves to provide a thick protective layer (Ari et al., 2018, Yousef 
and Sharma, 2018) 
Epidermal keratinocytes become further differentiated as they progress outward, 
initially losing the ability to proliferate and then a switching of several cytoskeletal 
gene expression, specifically silencing keratin (also termed cytokeratin, KRT or K) 
14 and keratin 5, and activating keratin 10 and 1.This is followed by densely 
packaging these cytoskeletal filaments together and collapsing the cell, creating in a 
protein envelope (the cornified envelope) around the cell, which is then crosslinked 
with nearby cells, generating a fully functional and robust barrier system.  
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This process follows a predictable path and while most mechanisms controlling this 
process are well understood, especially in mice, some aspects remain elusive. 
Specifically the non-linear increase in timeframe to obtain a complete functional 
barrier in human development, as well as the wave like induction of hair follicles in 
mouse models vs human models and the inherent differences in skin elasticity 
between mammalian species (de Jong et al., 2017, O'Brien et al., 2019, 
Orzechowska et al., 2018)  
1.1.2 Cellular changes underlying epidermal morphogenesis and homeostasis 
in murine models 
The model of mouse epidermal development is well studied and follows a well-timed 
and predictable progression, epidermal development occurs during embryogenesis, 
during the gastrulation stage, the three germ layers form, the outermost of these 
layers (the ectoderm) will go on to form the epidermis, nervous system, teeth as well 
as several other tissues. At embryonic day (E) 9.5 the basal epidermal layer is 
established, keratins 5 and 14 expression is vital to this process (Liu et al., 2013, 
Lee et al., 2018), this layer maintains its proliferative ability and contains 
keratinocyte progenitor cells, which will be maintained throughout the host lifetime 
and will proliferate in order to maintain the mature epidermis. By E14.5 the 
intermediate layer forms, this is a transient layer only found during epidermal 
development, its formation is directly associated with the initiation of epithelial 
stratification, During the early stages of epidermal stratification cells in the 
intermediate layer maintain a minor proliferative ability, this allows for expansion of 
the intermediate layer as well as allowing some of the basal cells to continue 
proliferating symmetrically maintaining the basement membrane accommodating the 
rapidly expanding embryo, in the late stages of stratification asymmetric basal cell 
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proliferation reaches up to 70%, at this point the ability to proliferate is lost in 
intermediate layer cells (Lechler and Fuchs, 2005). By E16.5 the cornified layer 
begins to form, with full barrier acquisition of the whole epidermis completed by 
E18.5. It is also worth noting that during epidermal development an additional layer 
is present at the early stages, the periderm, this is a transient layer which is lost 
around E14.5. (Koster and Roop, 2007, Blanpain and Fuchs, 2006, Zhu et al., 2014) 
(This process is summarised in Fig.1.1). 
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Figure 1.1 Summary of epidermal differentiation and homeostasis  
 
a) Epidermal development in mouse beginning at E8.5, progressing to E18.5, 
common differentiation markers are shown, b) mature human thick epidermis, 
highlighting the 5 layers and several additional cell types and processes. 
Images adapted from (Forni et al., 2012, Natarajan et al., 2014).  
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1.1.3 Cellular changes underlying epidermal morphogenesis and homeostasis 
in human models 
Human epidermal development occurs in much the same way as with mouse, but 
with an altered and much longer timeframe, with basal layer initiation occurring at 
approximately week 8, intermediate layers forming in weeks 9 and 10, the cornified 
layer beginning to form at the end of week 10, however full barrier acquisition does 
not occur until a much later stage, approximately week 22 (Coolen et al., 2010).  
The periderm is also present during human epidermal development, forming at 
approximately week 5 and being lost at week 22, in humans the periderm undergoes 
cycles of keratinization and desquamation and produces a waxy substance (the 
Vernix caseosa) which serves to protect the foetus from the amniotic fluid, and later, 
bacterial assault when leaving the birth canal, while the periderm is lost at week 22 
the vernix caseosa remains until shortly after birth (Schlessinger and Bhimji, 2018). 
However despite the longer timeframe the same keratins are present at each stage 
and serve highly similar functions to their mouse counterparts (Liu et al., 2013, 
Sotiropoulou and Blanpain, 2012, Zomer and Trentin, 2018).  
The basal layer is the lowest layer of the epidermis and serves two primary 
functions; - firstly, adhesion of the epidermis to the underlying dermis via the 
basement membrane (BM), this is facilitated by hemi-desmosomes and a variety of 
additional anchoring filaments, anchoring fibrils and integrins, taken together these 
form hemi-desmosome (HD)-anchoring filament complexes, which form tight 
junctions between basal keratinocytes and the BM, this adhesion serves to protect 
tissues from mechanical forces and shear stressors (Yurchenco, 2011, Jayadev and 
Sherwood, 2017). Secondly, many cells of the basal layer are capable of 
proliferation and divide in order to replace the corneocytes lost during normal 
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shedding; this requires a tightly regulated balancing act to be maintained between 
proliferation and quiescence, the keratinocyte progenitor cells of the basal layer 
proliferate asymmetrically to the BM, this produces one basal cell and one 
suprabasal cell, the basal cell remains in contact with the BM via integrins, which 
maintains the proliferation environment, while the suprabasal cells no longer 
receives proliferative signals and instead commit to differentiation, as basal layer 
divisions continue the suprabasal cell is pushed further outward, continuing to 
differentiate (Blanpain and Fuchs, 2009, Sotiropoulou and Blanpain, 2012). Cells 
present in the basal layer express K5 and K14; these are often held as markers of 
the epidermal progenitor cells. 
Once keratinocytes move outward they enter the spinous layer, the first stage in 
terminal differentiation, once here cells are no longer attached to the BM and lose 
the ability to proliferate, protein expression also significantly change, with the most 
notable change being a loss of K5/K14 and the appearance of K1/K10, an 
abundance of desmosome complexes are also present, resulting in more tight 
junctions between cells, making the whole epidermis more rigid, as well as 
maintaining the overall integrity of the epidermis (Simpson et al., 2011, Seltmann et 
al., 2013). 
The granular layer consists of keratinocytes in the late stages of differentiation, 
keratinocytes in this layer contain large amounts of profilaggrin in keratohyalin 
granules, profilaggrin is a protein which, when dephosphorylated becomes 
proteolysed, the created fragments (free filaggrin) are capable of binding to keratin 
monomers and arranging them into parallel bundles, this bundling causes a collapse 
of the cell and extensive cross-linking of the keratins together with the cornified 
envelope proteins (loricrin, involucrin, late cornified envelope protein etc.), 
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generating an insoluble keratin matrix, which will form the scaffold upon which the 
cornified envelope will be built (Sandilands et al., 2009, Elias et al., 2014). 
The cornified layer is the final product of epidermal differentiation, corneocytes are 
non-viable cells, having degraded or ejected their nucleus and other ‘vital’ 
organelles, the plasma membrane is also lost and replaced with a crosslinked 
ceramide layer, the cornified envelope, at this point cells are now large and flat. 
Corneocytes are also very tightly bound to each other, and any intercellular spaces 
which are present are filled with lipid acting as a hydrophobic matrix, further 
increasing the inpermeability of the cornified layer (Abdayem et al., 2016). The final 
result is a robust and functional barrier, capable of withstanding harsh environmental 
hazards as well as mechanical and microbial stressors and preventing dehydration 
of the organism. 
1.1.4 Key cell signalling pathways controlling epidermal morphogenesis  
Epidermal lineage is determined primarily by antagonistic interplay between 
wingless-related integration site (WNT) signalling and bone morphogenetic protein 
(BMP) signalling, as well as several other cell signalling molecules. The ectoderm 
has the potential to differentiate into epithelial or neuronal lineages, WNT signalling 
is central to an antagonistic signalling system in place to selectively activate either 
epidermal or neuronal cells lineages (Fuchs, 2007, Davidson et al., 2012, Yoney et 
al., 2018). Ectodermal cells with high levels of WNT stop responding to fibroblast 
growth factors (FGFs), this prevents the inhibition of BMP and drives ectodermal 
cells into the epidermal lineage. However, if the levels of WNT are low, FGF 
signalling remains unhindered, inhibiting BMP signalling and driving ectodermal cells 
into a neuronal fate (Fuchs, 2007, Wilson et al., 2001). 
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On the cell surface WNT ligands bind the frizzled (FZD) receptor and a low-density 
lipoprotein receptor-related protein 5 or 6 (LRP5/6) to form a larger complex within 
the cell membrane, this complex recruits intracellular protein dishevelled (DVL) 
which inhibits the phosphorylation of β-catenin, preventing its degradation in 
cytoplasm and allowing it to accumulate and translocate to the nucleus where it 
binds lymphoid enhancer binding factor/transcription factor (LEF-TCF) transcription 
factors facilitating changes in gene expression (MacDonald and He, 2012). 
WNT/β-catenin is also required in neural crest cells, also derived from the ectoderm, 
in order to generate melanocytes, which provide both pigmentation and protection 
from UV-B Radiation. A loss of Wnt1 or Wnt3a, in mice, results in a loss of 
melanoblasts (precursors of mature melanocytes) (Ikeya et al., 1997), later studies 
also demonstrated that Wnt/β-catenin activation in neural crest cells was sufficient 
to override lineage selection, resulting in melanocyte fate selection rather than other 
neuronal lineages (Dorsky et al., 1998, Mort et al., 2015). More recent studies have 
suggested that WNT signalling may actually inhibit pigmentation, use of ICG-001, a 
chemical inhibitor of WNT signalling resulted in an increase of pigmentation in 
human melanoma cells (Kim et al., 2016), which is counter to the previous mouse 
based studies which supported WNT/β-catenin inhibition has a hypopigmentation 
effect (Yamaguchi et al., 2009).   
Taking these studies into account, it is clear that WNT signalling is vital to epidermal 
development and regulating skin pigmentation. 
BMP ligands bind to BMP receptors (BMPR) on the cell surface, resulting in 
phosphorylation of SMAD1/5/8  C-termini, allowing for the formation of a trimer of 
two SMAD1/5/8 proteins and one smad4 protein, SMAD4 facilitates the translocation 
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of SMAD1/5/8 to the nucleus, activated smads interact with other transcription 
factors to facilitate a variety of cell specific processes (Xiao et al., 2007, Hill, 2016).  
BMPs are vital to the early stages of embryonic development, but they are also 
required for postnatal development/cell differenation, as demonstrated by their 
presence in mesoderm and ectoderm tissues. There are several BMP ligands and 
receptors, which are expressed differently throughout the developing epidermis, 
BMPR-1A and BMP-7 are only detected in the basal layer, meanwhile BMPR-1B 
and BMP-6 are absent in basal layer cells, but found in the suprabasal layer 
(Botchkarev, 2003), this suggests that the role of specific BMPs is to facilitate either 
proliferation (BMPR-1A and BMP-7) or differentiation (BMPR-1B and BMP-6) in 
keratinocytes (Botchkarev, 2003, Panchision et al., 2001, Fessing et al., 2010). 
Stratification of the epidermis occurs during the formation of the intermediate layer, 
and is highly dependent upon the mitotic spindle, which regulates the polarity of 
epidermal cells, with the apical end facing towards the outer, more differentiated cell 
layers, while all other sides are in contact with adjacent cells, in the basal layer, the 
basal region interacts with the BM and the extracellular matrix (ECM) therein 
(Ahringer, 2003, Lazaro-Dieguez et al., 2013)  
Keratinocyte polarisation is well studied, but less understood than other simple 
epithelial polarisation, as mentioned the shift of the mitotic spindle is a key event in 
stratification, as cells begin proliferating in a ‘stacked’ fashion (Blanpain and Fuchs, 
2009). The mechanism by which the mitotic spindle shifts to the apical region is 
fairly well understood in other species (Drosophila melanogaster and C.elegans), 
which has helped to, at least partially, identify the mechanism responsible in 
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humans and other mammals (Gillies and Cabernard, 2011, Poulson and Lechler, 
2010, Lazaro-Dieguez et al., 2013). 
PAR-3 is a polarity protein, which marks the apical edge of a cell with the ‘polarity 
landmark’, PAR-3 along with two other proteins, insecuteable and LGN, which 
recruits the mitotic spindle to the apical edge, although this mechanism not fully 
understood, it is known that a loss of either PAR-3, insecuteable or LGN results in a 
loss of asymmetrical proliferation, and an increase in symmetrical proliferation (Hao 
et al., 2010, Ray and Lechler, 2011).  
The final stage of epidermal development is to establish the barrier, the cornified 
layer, a cluster of highly specific genes are required to establish the barrier, these 
genes are found in a gene rich region of chromosome 1 in humans (chromosome 3 
in mice), this region is termed the epidermal differentiation complex (EDC) 
(Mardaryev et al., 2014, Kypriotou et al., 2012). The EDC encodes many of the 
structural proteins which make up the cornified envelope; Involucrin, loricrin, and 
small proline-rich proteins (Sprr). Which become cross-linked by transglutaminases 
(Tgms), Tgms activity is calcium dependent, as such the formation of the barrier is 
dependent upon extracellular calcium ions (Ca2+) (Bikle et al., 2012). Elevated 
extracellular Ca2+ increases the amounts of intracellular Ca2+, generating a Ca++ 
gradient increasing from basal to cornified layer, high levels of extracellular Ca2+ are 
detected by the calcium sensing receptor (CaR), a G-protein coupled receptor, 
which is found more predominantly in suprabasal (spinous and granular layer) cells 
and when activated by extracellular calcium triggers the mobilisation of E-cadherin 
to the plasma membrane, facilitating cell-cell adhesion, as such a loss of CaR 
results in abnormal differentiation and incomplete barrier formation (Tu et al., 2007, 
Tu et al., 2012, Tharmalingam and Hampson, 2016). It is also worth noting that 
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when culturing primary keratinocytes in vitro the addition of calcium to the media is 
sufficient to induce differentiation, the mechanism of differentiation is highly similar 
to the in vivo mechanism of differentiation (Bikle et al., 2012). 
1.1.4 Key transcription factors controlling epidermal morphogenesis and 
homeostasis 
Mouse studies have identified several transcription factors which play a role in the 
epidermal differentiation and stratification process (mad/max, c-Myc,  AP-1 and AP-
2, Klf4, Znf750 to name some), one related transcription factor that is fairly 
extensively studied is p63 (also known as Trp63), a master regulator of epidermal 
differentiation and development. p63 is a transcription factor and has been shown to 
directly regulate the expression of several genes vital to the epidermal differentiation 
program, including K5 and K14, cellular adhesion molecules P-cadherin and 
integrin-α3, as well as activating or repressing other transcription factors, including 
AP-2 and the epigenetic regulators Satb1,Brg1 and Cbx4 (Romano et al., 2007, 
Romano et al., 2009, Fessing et al., 2011, Mardaryev et al., 2014, Koster and Roop, 
2007, Botchkarev et al., 2012, Ihrie and Attardi, 2005, Vanbokhoven et al., 2011). 
P63-/- mice fail to generate a stratified epidermis, they also lack all epidermal 
appendages, glands, and fail to express K5 or K14. Death occurs shortly after birth 
due to significant water loss as a result of the barrier defects (Mills et al., 1999, Yang 
et al., 1999). Heterozygous p63 defects in humans have also been linked to several 
ectodermal dysplasia syndromes, which are characterised as abnormal 
development of epidermis, teeth, hair, nails, sweat glands etc. (Koster, 2010). 
p63 has two promoter regions and so two distinct isoform groups, the first promoter 
region generates full length protein containing a N-terminal transactivation domain, a 
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DNA binding domain and a C-terminal oligomerisation domain, while the alternative 
promoter results in a p63 protein which is lacking the transactivated N-terminal, but 
maintains the DNA and C-terminal domains (these isoforms are termed TAp63 and 
∆Np63 respectively) (Yang et al., 1998, Soares and Zhou, 2018), these isoforms 
have shown distinct, but partially overlapping roles in regulation of both epidermal 
differentiation and stratification. It has been shown that ∆Np63α (a splice variant of 
∆Np63) was the most abundantly expressed p63 isoform and is predominantly 
expressed in the basal layer of the epidermis, while it is almost completely absent in 
the suprabasal layers (Romano et al., 2012). Specific investigation into ∆Np63α and 
Tap63 has shown that ∆Np63α has a significant role in regulating epidermal 
differentiation while Tap63 acts to protect keratinocytes from senescence and 
repress tumour formation (Koster et al., 2007, Truong et al., 2006, Guo et al., 2009, 
Romano et al., 2012). 
In suprabasal cells P63 has been shown to regulate notch signalling pathway, which 
is important during keratinocyte differentiation. Notch signalling is activated when 
Notch ligand expression in the basal cells is activated by forkhead box N1 (foxn1)  
the Notch ligand protein then binds and activates Notch receptors, a proteolytic 
cleavage occurs releasing the notch intra-cellular domain (NCID) which is 
translocated to the nucleus, where it facilitates the binding of transcription factors to 
target genes, this activation also synergistically effects AP-2 to activate expression 
of the CCAAT/enhancer-binding protein-α/β (C/EBP-α/β) transcription factors to 
facilitate the activation of genes required in suprabasal keratinocytes, including K1 
and 10, while simultaneously repressing the basal layer specific genes K5 and K14 
(Blanpain and Fuchs, 2009, Kolev et al., 2008, Wang et al., 2008). TAp63α also 
indirectly activates AP-2 during this process. p63 also activates the IKK-α complex 
which phosphoylates the inhibitor of κB (IκB) inactivating it which inturn activates 
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Nuclear Factor κB (NF-κB) resulting in the inhibition of proliferation in suprabasal 
cells and activation of epidermal stratification (Koster and Roop, 2007, Takeda et al., 
1999, Koster et al., 2006) . 
In addition to p63 several other key transcription factors have been determined to 
play a vital role regulating the expression of EDC genes (and the acquisition of the 
epidermal barrier), including; krüpple like factor 4 (klf4), grainyhead like epithelial 
transactivator (Grhl3/Get1), aryl hydrocarbon receptor nuclear translocator (Arnt), 
activator protein 1 and 2 (AP-1 and AP-2) (Kypriotou et al., 2012). Diminished or 
elevated levels of Klf4 is linked to defects in the barrier formation or accelerated 
barrier formation, respectively, while mutations in Grhl3/Get1 result in barrier defects 
due to a down-regulation of key genes responsible for lipid metabolism and cell-cell 
junction formation (Yu et al., 2006b). 
The wide array of transcription factors activate the late stage differentiation genes 
within the EDC, which can only occur after chromatin remodelling complexes 
establish the specific three dimensional chromatin structure required to facilitate 
gene activation. p63 has been shown to directly regulate expression of chromatin 
organisation and remodelling genes Satb1 and BRG1, which are important in this 
process, loss of either BRG1 or Satb1 leads to defects in epidermal differentiation 
(Fessing et al., 2011, Mardaryev et al., 2014). 
1.2 Hair follicle morphogenesis 
The hair follicle is a complex micro-organ which is found in the majority of human 
skin, with the exceptions of the palms, soles and lips. Hair is one of the defining 
characteristics of mammals, with almost all mammals being covered with hair; 
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however, there are some exceptions to this, most fall into the Cetaceans group of 
aquatic mammals containing dolphins, whales and porpoises, but there are others. 
Mammalian hair serves a variety of functions, ranging from protection and sensory 
perception to social interactions and attracting a mate (Stenn and Paus, 2001, 
Ramos and Miot, 2015). Anatomically speaking the mature hair follicle is made up of 
several key regions, from the lowest point the bulb, the isthmus and the 
infundibulum which is continuous with the epidermis. The hair follicle bulb is 
comprised of the dermal papilla (DP), the matrix and the pre-cortex, the isthmus is 
the region between the arrector pilus and sebaceous gland, which houses the bulge 
region, while the infundibulum is the uppermost region, from the sebaceous gland to 
the epidermis, the hair shaft as well as the connective tissue sheath (CTS) and outer 
root sheath (ORS) run through three regions, while the inner root sheath runs 
through the bulb to the isthmus (summarised in Fig. 1.2a). 
The DP is a tightly packed cluster of specialised fibroblasts which are almost 
completely surrounded by the HF matrix and pre-cortex, suffice a small region at the 
base, which is connected to the CTS which serves as a connection point to the 
circulatory system (Alonso and Fuchs, 2006, Yoshida et al., 2019). The DP is 
responsible for controlling hair follicle morphogenesis and cycling. It also regulates 
the size of the overall follicle by controlling the number of matrix cells present within 
the HF, the DP is the only part of the lower follicle not degraded during cycling due 
to its role in regulating the signalling pathways required to regenerate the hair follicle 
(Alonso and Fuchs, 2006, Paus and Cotsarelis, 1999, Driskell et al., 2011, Chi et al., 
2010, Gupta et al., 2018). The matrix region is largely made up of undifferentiated 
cells (also termed transit-amplifying cells), which are capable of a limited amount 
proliferation before expanding upwards, towards the pre-cortex region of the supra-
bulb where they will terminally differentiate either to hair shaft or inner root sheath 
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(IRS) cell fates (Oshima et al., 2001). The pre-cortex is also interspersed with 
melanocytes, which produce pigmentation granules ultimately giving the hair shaft 
its colour (Alonso and Fuchs, 2006, Kauser et al., 2011, Samuelov et al., 2013). The 
hair shaft itself is made up of terminally differentiated keratinocytes (trichocytes), 
which arise from the transit-amplifying cells of the matrix, the shaft itself is 
comprised of three layers; the cuticle, the cortex and the medulla, overall 
appearance of the hair itself its determined by the pigmentation level and structure 
of these 3 layers (Miteva and Tosti, 2013). 
The isthmus is the middle region, and is relatively devoid of any special features 
with the exception of the bulge region, the bulge region houses the stem cells of the 
hair follicle, in mice it is easily identified as a physical bulge of cells located in the 
outer root sheath between the sebaceous gland and the arrector pili muscle, and is 
home to several stem cell populations, which give rise to epithelial cells, 
melanocytes and neural crest-like cells (Yu et al., 2006a, Ito et al., 2005, Yu et al., 
2010). However, in humans the bulge regions is less easily identified, as the region 
does not prominently bulge out, although the stem cell niche is still located between 
the sebaceous gland and arrector pili muscle. The stem cell niche is vital to hair 
follicle cycling and regeneration, hair follicle stem cells (HFSCs) are responsible for 
self-renewal of the follicle, maintaining HF homeostasis, are able to give rise to 
sebaceous glands and assist in epidermal wound healing (Ito et al., 2005). In adult 
mice bulge cells have also been shown to be able to generate de novo hair follicles 
in extreme epidermal wound response (Ito et al., 2007), Other than the bulge region, 
the isthmus contains the anchoring points for the arrector pilus, sebaceous gland 
and apocrine gland. 
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The infundibulum is the upper most region of the HF and is contiguous with the 
epidermis, and so the epidermal cells here are capable of migrating to the epidermis 
in response to wounding, the infundibulum also contains the connecting points of 
glandular epidermal accessory appendages (sebaceous and apocrine glands etc.) 
facilitating secretion (Ramos-e-Silva and Pirmez, 2014).  
The IRS is also keratinised, in order to provide a rigid structure and facilitate the 
overall shape of the HF, the IRS is also made up of 3 layers, from inner-most to 
outer-most; the IRS cuticle, the Huxley’s layer and the Henle’s layer, the Huxley and 
Henle layers contain trichohyalin granules which facilitate cross-linking, providing 
rigidity (Joshi, 2011, Westgate et al., 2017). The ORS is essentially a pouch of 
epidermis containing the whole HF, the ORS is a stratified epithelia which is 
continuous with the epidermis, the ORS serves as an anchoring point for the 
arrector pili muscle, additionally the ORS is not keratinised below the isthmus (as 
the IRS is keratinised below this point), the ORS in the isthmus is also the specific 
location of the bulge region, and the HFSC (Vidal et al., 2005). The CTS is a 
mesenchymal tissue which surrounds the HF and is dynamically modified during HF 
cycling, the CTS predominantly contains type I collagen fibres, the distribution and 
orientation of these fibres is dependent upon HF cycling, the CTS also contributes to 
maintaining the dermal matrix. (Ito and Sato, 1990, Oh et al., 2012). 
1.2.1 Hair follicle structure and functions 
The structure and function of the HF is dependent upon its cycling stage, generally 
when discussing the HF it is assumed to be an anagen stage follicle (unless stated 
otherwise), this is the period of growth and normal function of the HF. During the 
anagen phase the HF is growing and elongating, the matrix cells are highly 
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proliferative, with most of the proliferation occurring at the lowest part of the matrix, 
below Auber’s line, an arbitrary boundary that crosses the widest part of the DP 
representing the changing matrix cell focus from proliferation (below) and trichocyte 
differentiation (above) (Alonso and Fuchs, 2006, Driskell et al., 2011). The matrix 
cells differentiate into both IRS and hair shaft (HS), IRS cells in the lower bulb have 
already differentiated, losing their proliferative ability, and will continue to move 
upwards as more IRS cells are added to its base, the IRS is lost at the sebaceous 
gland entry point, and cells of the IRS are sloughed off and degraded, meanwhile 
cells becoming HS will move towards the pre-cortex region, between the Auber line 
and the start of the HS cortex, starting their differentiation as they progress, once at 
the cortex region the keratinocytes will have fully differentiated into trichocytes 
(Purba et al., 2016). While most proliferation occurs in the matrix the ORS shows 
some proliferation intermittently throughout, as the ORS supports growth of the HF 
the proliferation likely serves to facilitate this, the bulge regions of ORS only 
proliferate during the early anagen stage, as anagen continues this proliferation 
ceases and the bulge region enters quiescence, (Purba et al., 2016), the major 
features of anagen follicles are shown in the expanded section of Fig 1.2a. 
1.2.2 Cellular changes underlying hair follicle morphogenesis 
HF development begins at E14.5 in mice and approximately 9 weeks gestation in 
human, HF generation involves a series of complex cross-talk events between the 
epidermis and the underlying mesenchyme. HF initiation begins with a 
mesenchymal signalling event, the ‘first dermal signal’ which facilitates the 
thickening of the epidermis and the formation of the HF placode, once formed the 
placode signals to dermal cells, which cluster below it forming the specialised 
dermal cell cluster, this is the ‘second dermal signal’ (Fu and Hsu, 2013), it is also 
 20 
 
worth noting that this initiation process is the same in generating the feather bud or 
scale placode (Dhouailly, 1973, Olivera-Martinez et al., 2004, Di-Poi and 
Milinkovitch, 2016). The clustered dermal cells (also termed the dermal condensate) 
migrates downwards into the dermis, while the epidermal cells proliferate 
downwards, following and then encompassing the clustered dermal cells which 
becomes the dermal papilla, this structure is termed the ‘hair peg’, at this point the 
DP signals to initiate the formation of the IRS, providing the rigid structure for the HF 
to continue developing, the ORS begins to surround the IRS as a continuation of the 
epidermis, and cells between the IRS and DP become matrix cells and begin 
differentiating to form the hair shaft layers, which will then elongate and protrude 
through the epidermis (Duverger and Morasso, 2009) This process is summarised in 
Fig 1.2b).  
1.2.3 Key cell signalling pathways controlling hair follicle morphogenesis 
As follicular development is highly dependent upon the signalling interactions of 
dermal and epidermal cells, the signalling pathways are highly regulated; however 
the key signalling mechanisms are highly similar to those seen in epidermal 
development and homeostasis, as the generation of thickened epidermis and 
gathering of dermal condensate is seen in the initiation of feathers, scales and hair it 
is likely that a conserved first dermal signal exists, however it has yet to be 
identified. To date several conserved signalling pathways have been identified in HF 
development including; WNT, BMP, sonic hedgehog (SHH), notch and 
ectodysplasin A1 (EDA).  
Of all the conserved signalling pathways the WNT/β-catenin signalling pathway is 
seen as one of the most vital. As previously mentioned WNT signalling results in 
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accumulation of cytoplasmic β-catenin, which is translocated to the nucleus where it 
activates or represses gene expression programmes (MacDonald and He, 2012), 
and WNT/β-catenin signalling has been identified in both epidermal and 
mesenchymal development (Andl et al., 2002, Zhang et al., 2008, Fu and Hsu, 
2013). Several studies have shown that β-catenin is required to initiate HF 
development, however the origins of WNT signalling and if WNT/β-catenin alone is 
the first dermal signal remains to be proven (Rishikaysh et al., 2014). 
EDA and its receptor (EDAR) have also been implicated in placode development, 
although EDA/EDAR mutant mice still developed secondary placodes (including 
mammary placodes and dental placodes) but failed to generate primary placodes, 
responsible for guard hairs (Mikkola and Thesleff, 2003). Meanwhile in humans 
EDA/EDAR mutations lead to hypohidrotic ectodermal displaysia, characterised by 
malformed teeth, sparse hair coverage and failed development of several exocrine 
glands, placodes formed also have an irregular or fused borders, suggesting that 
EDAR is more vital for the development, rather than the initiation of hair placodes. 
EDAR is regulated by WNT/β-catenin and NF-κB pathways (Durmowicz et al., 2002, 
Schmidt-Ullrich et al., 2006), and is seen to activate SHH signalling as well as 
inhibiting BMP (which is known to inhibit placode development), demonstrating a 
dual function for the EDA/EDAR/NF-κB pathway in the developing placodes 
(Pummila et al., 2007). 
Upon formation of the placode another signalling event recruits dermal fibroblasts to 
cluster below the placode, formation of this dermal condensate is mediated by 
fibroblast growth factor (FGF) 20, which is activated by Edar and the Wnt/β-catenin 
pathway in the newly formed placodes (Huh et al., 2013). Initiation of placodes 
requires a downregulation of keratinocyte growth factors (KGF) and epidermal 
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growth factors (EGF), while Kgf and Egf are still present, their receptors are 
degraded, preventing interaction, although the precise mechanism is as yet 
unknown (Richardson et al., 2009). 
Once the placode and dermal condensate are formed a large increase in 
keratinocyte proliferation is seen, marking the start of HF organogenesis and the 
second dermal signal. Eda/Edar/NF-κB signalling drives expansion of the placode 
downward via activation of Shh, which in turn activates cyclin D1, triggering a rapid 
proliferation event in epidermal cells (Schmidt-Ullrich and Paus, 2005, Schmidt-
Ullrich et al., 2006, Mill et al., 2003). Additionally Shh signalling also has a function 
in the dermal condensate, through a complex crosstalk between epidermal and 
mesenchyme cells, Shh based activation of Noggin, drives maturation of the dermal 
condensate to the DP, which is vital for mouse HF morphogenesis (St-Jacques et 
al., 1998, Blanpain and Fuchs, 2006, Millar, 2002). Tgf-β2 is also required for the 
downward proliferation seen in organogenesis; Tgf-β2 activates Snail and Mapk in 
the expanding epidermal cells, which in turn regulates proliferation and cell 
adhesion, supporting that loss of Tgf-β2 or Snail result in halted proliferation 
(Jamora et al., 2005).  
The downward expansion of the hair peg and subsequent enveloping of the dermal 
condensate trigger an increase in proliferation and differentiation of the epithelial 
cells in the hair peg, this requires a myriad of signalling molecules, as well as 
precise sequence of events, ensuring that differentiation occurs normally, however 
only a handful of signalling molecules have been fully investigated, leaving some 
specific events unknown. The hair peg now begins to form the additional layers 
which make up the HF; beginning with the IRS, then onto the ORS and hair shaft, 
central to this is Bmp and Notch signalling cascades (Powell et al., 1998, Rendl et 
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al., 2008). BMPRIA (the only Bmp receptor currently detected in hair follicles) is 
required for both IRS and hair shaft differentiation, as such Bmp4 triggers IRS 
differentiation via activation of BmpRIA, which in turn activates several IRS genes 
via Gata3 activation as well as up-regulating Bmp levels, creating a feedback loop 
(Kobielak et al., 2003, Nemer and Nemer, 2003). Hair shaft differentiation is 
antagonistically regulated by Wnt signalling and BmpRIA, via repeated bouts of 
inhibition and activation BMPRIA in progenitor cells maintains levels of β-catenin 
and lef1 at the specific point required for HF keratin expression and hair shaft 
formation (Kobielak et al., 2003). 
Notch signalling has been shown to be involved in numerous cell fate decisions in a 
variety of cell types, during HF development notch is required to activate 
proliferation in the DP, in response to epidermal growth factor (Egf) as well as 
activating transcription of survivin, an apoptosis inhibiting protein, demonstrating that 
Notch signalling is required for the maintenance of the DP and the hair follicle as a 
whole (Zhang et al., 2016). 
1.2.4 Key transcription factors controlling hair follicle morphogenesis 
Control of the gene expression programmes required for HF development is 
facilitated by a handful of specific transcription factors. As previously stated, p63 -/- 
mice fail to generate a stratified epithelia and lack all epidermal appendages, 
including hair, glands and teeth, demonstrating that p63 is vital to the development 
of hair follicles, however the specific mechanisms of p63 action during HF 
development remain to be elucidated. Additional mouse based studies into p63 have 
shown that when ∆Np63α was overexpressed (using a Tet-inducible under the 
control of Krt5), mice showed enlarged HF size and an expanded ORS, as well as 
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decreased proliferation in matrix cells and failure to differentiate into both hair shaft 
and IRS, instead the keratinocytes displayed markers of interfollicular epidermis, all 
down regulated genes are targets of Wnt/β-catenin signalling and so p63 regulates 
Wnt signalling in order to activate IRS and hair shaft specific genes (Romano et al., 
2010). 
As well as p63 there are several other key transcription factors, including; 
Lim/Homobox protein 2 (Lhx2), Forkhead box protein N1 (FoxN1), Snail 1 zinc finger 
protein (Snail), GATA binding protein 3 (Gata3) and Homeobox protein Hox8 
(Msx2). Most are involved in establishing the specific cell differentiation programmes 
in the cyto-differentiation stage of HF morphogenesis; for example, Gata3 regulates 
IRS differentiation, while Msx2 and FoxN1 regulate hair shaft differentiation (Ma et 
al., 2003, Johns et al., 2005), FoxN1 is also required for pigmentation of the shaft as 
it directly regulates the transfer of pigment from melanocyte to hair shaft cortex 
(Weiner et al., 2007). Snail is a target of Tgf-β, and serves to regulate cellular 
adhesion and proliferation in the hair bud, a loss of Snail or Tgf-β stalls HF 
morphogenesis (Jamora et al., 2005). Lhx2 is crucial in formation and maintenance 
of the bulge region, during hair follicle morphogenesis Lhx2 is a marker of the hair 
bud, and its ablation results in cellular disorganisation and transformation into a 
sebaceous gland (Folgueras et al., 2013). 
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Figure 1.2 Human hair follicle structure and mouse hair follicle morphogenesis 
a) Structure of the mature human hair follicle (ai) and expanded bulb region (aii) key 
features of anagen follicles are highlighted. b) Illustration of murine hair follicle 
morphogenesis, highlights key structures. Images adapted from (Krause and Foitzik, 
2006, Millar, 2002). 
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1.3 Hair cycling 
Postnatally the hair follicle undergoes repeated cycles of growth, shrinkage and rest 
(anagen, catagen and telogen (respectively), then back to growth (summarised in 
Fig. 1.3). Each cycle can take several years to complete in humans (Schneider et 
al., 2009, Paus and Cotsarelis, 1999, Alonso and Fuchs, 2006), while it takes 
approximately three weeks in mice, although the overall process remains highly 
similar. 
 1.3.1 Cellular changes during hair cycling 
Anagen phase follicles tend to be long and straight, although at an angle to the skin 
surface, this is to facilitate flattening (as previously described). The length of anagen 
phase determines the overall length of the hair and is highly dependent on 
continued proliferation and differentiation of the matrix transit-amplifying cells 
(Alonso and Fuchs, 2006). Usually the majority of human hairs on the scalp and 
beard are in the anagen phase (approximately 90%) (Oh et al., 2016). 
Anagen-to-Catagen transition has been extensively studied. In young mice this 
transition can be observed, due to young mice having a synchronised hair cycle up 
to an age of 12 weeks, humans do not have a synchronised hair cycle making it 
significantly more difficult to accurately study. Additionally murine anagen-to-
catagen occurs in a wave, beginning at the head and travelling down the animal to 
the tail. However, in humans no such visible wave is seen; with very few human 
follicles being in catagen (or transitioning to catagen) phase at any given time (Oh et 
al., 2016). 
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Catagen phase is when the lower follicle detaches from the dermal papilla and 
regresses to roughly 1/6th of its original size, through a programmed cell death in the 
hair bulb, IRS and ORS, hair shaft differentiation also ceases and a ‘club’ forms at 
the base of the shaft as it migrates towards the upper follicle region (where it 
anchors in place until shedding), as the majority of the lower follicle has degraded 
an ‘epidermal stand’ remains, as a means to connect the DP to the upper follicle 
(Alonso and Fuchs, 2006, Lindner et al., 1997, Sasaki, 2019). 
Finally telogen phase is a time of rest, in mice the first telogen phase is short, lasting 
only a day or two, but subsequent telogen phases last progressively longer (Muller-
Rover et al., 2001, Wu et al., 2019a). In humans telogen phase lasts several 
months, although hair shaft tends to remain attached, but not growing, to the upper, 
permanent part of the hair follicle, so little visible loss of hair is seen. During this 
stage the dermal papilla is also retracted towards the bulge region, leaving a short 
distance between the bulge and dermal papilla, facilitating interactions between the 
secondary hair gem and the bulge region (Greco et al., 2009, Uccelli et al., 2019). 
Telogen-to-Anagen transition occurs with quiescent stem cells being signalled to 
rapidly proliferate, forming a new bulb, complete with new transit-amplifying cells 
(Blanpain et al., 2004). The newly formed hair shaft is formed adjacent to the 
anchored club hair left over from the previous cycle, and will force it to detach and 
subsequently be shed (also termed exogen), the process is similar to the 
organogenesis stage of follicular development with Wnt and shh signalling being 
required for adequate regeneration (Lo Celso et al., 2004, Callahan et al., 2004, 
Sasaki, 2019). 
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1.3.2 Key cell signalling pathways controlling hair cycling and regeneration 
Generally speaking mouse models have been the cornerstone of hair follicle cycling 
studies, due to the ease of obtaining samples and the well-defined timeline, 
although the same (or highly similar) mechanisms are thought to control the human 
hair cycling. The same cell types and cell cycling transitions occur, however there 
are several marked inter-species differences, chiefly the timing of cycling transitions, 
with the anagen phase lasting years in humans, while in mice it is only 2-3 weeks. 
Additionally, mouse hair cycling is synchronised across the animal up to the age of 
12 weeks, while human hair cycling is a mosaic, with individual follicles cycling 
independently of those around it (Oh et al., 2016) . As such, most information 
detailed below has been obtained using in mouse models; however the human 
systems are likely to be similar. 
During telogen phase the dermal papilla rests just below the bulge region, telogen-
to-anagen transition progresses due to dermal papilla-hair follicle stem cell 
crosstalk, mediated by Shh, Wnt and Bmp signalling interactions. High levels of 
Bmp4 maintain bulge cell quiescence by inhibiting Shh and Wnt; however during 
telogen-to-anagen transition Noggin inhibits Bmp4, allowing Shh and Wnt 
expression to be activated, upregulating β-catenin. β-catenin then accumulates in 
the hair germ and hair follicle stem cells, overriding quiescence and activating the 
cells, which proliferate rapidly and become transiently-amplifying daughter cells 
(Rishikaysh et al., 2014, Greco et al., 2009).  
Anagen-to-catagen transition has several molecular markers; however their 
mechanism of action remains to be fully understood. Fgf5, Egf, Tgfβ family 
members, p53, and BmpRIA have all been shown to play a role in anagen-to-
 29 
 
catagen transition (Hebert et al., 1994, Andl et al., 2004, Schmidt-Ullrich and Paus, 
2005). Egf and its receptor (EgfR) drive catagen by regulating the RAS pathway, 
which promotes migration, senescence and differentiation (Rishikaysh et al., 2014). 
The RAS pathway inhibits Shh activity and may also regulate Fgf signalling 
(Mukhopadhyay et al., 2013). 
The onset of telogen is seen as Bmp signalling from the stem cell niche, triggering 
hair follicle stem cell quiescence, creating a threshold barrier which must be 
overcome to initiate the next cycle (Hsu et al., 2011, Wang et al., 2017). 
1.3.3 Transcription factors regulating hair cycling 
The transition from telogen-to-anagen is regulated by NF1C, a nuclear factor which 
is able to induce shh, Wnt and Lef1, which facilities the accumulation of β-catenin 
and subsequently overwhelms the Bmp barrier threshold, ending quiescence and 
driving proliferation as well as inhibiting Tgfβ1 and P21, and so initiating the anagen 
phase (Naruse et al., 2017, Plasari et al., 2010). 
As previously mentioned Sox9 and Lhx2 are required for maintenance of the bulge 
region while, Lhx2 is required for the initiation of the hair placode, in the mature hair 
follicle its role differs, it acts to regulate Sox9, Tcf4 and Lgr5 facilitating the switch 
between maintenance and activation of the hair follicle stem cells (Folgueras et al., 
2013). A loss of Lhx2 or Sox9, in mice results in an inability to maintain quiescence 
of hair follicle stem cells and early entry into anagen phase (Rhee et al., 2006). More 
recently, Lhx2 has been demonstrated to play a role in wound healing by facilitating 
proliferation and migration of bulge cells in response to wounding. A loss of Lhx2 
results in a reduced rate of wound healing and re-epithelialisation (Mardaryev et al., 
2011). Msx2 and Gata3 are also present during the anagen phase and serve a 
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similar role to the previously described one in hair follicle cyto-differentiation; Msx2 
facilitates differentiation of transit-amplifying cells to the hair shaft fate, while gata3 
drives differentiation to inner root sheath fate (Ma et al., 2003, Johns et al., 2005). 
Nuclear factor of activated T cells C1 (Nfatc1) is another transcription factor involved 
in regulation of the hair follicle stem cell niche, functionally Nfatc1 overlaps 
substantially with Lhx2 (Rhee et al., 2006, Horsley et al., 2008). The role of Nfatc1 
within bulge cells is to maintain quiescence, a loss of Nfatc1 results in premature 
transition into anagen phase (Horsley et al., 2008, Keyes et al., 2013). Nfatc1 is only 
seen in mouse hair follicle stem cell niche. However, increased human hair follicle 
growth and prolongation of anagen phase has been seen in patients when treated 
with Cyclosporine A (CSA) (an immunosuppressant) which is a known inhibitor of 
both human and mouse NFATc1. This increased growth is not a result of the T-cell 
inactivation as it has been demonstrated in immunocompromised nude mice (Gilhar 
et al., 1988), but instead due to the inhibitory effect of CSA on secreted frazzled-
related protein 1 (SFRP1) in the dermal papilla, SFRP1 has a bi-phasic effect on 
WNT signalling, high levels of SFPR1 inhibits WNT while low concentrations 
upregulate WNT, as such CSA inhibits SFRP1, which in turn upregulates WNT 
signalling to increase hair growth and prolong anagen phase (Zhong et al., 2007, 
Hawkshaw et al., 2018). 
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Figure 1.3 Human hair cycle 
 
Summary of the human hair cycle, highlighting the major stages. Image adapted 
from (Paus et al., 2013) 
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1.4 Epigenetic regulation of epidermal and hair follicle 
morphogenesis and homeostasis 
1.4.1 Epigenetics and chromatin structural organization  
Epigenetics is a term first coined in 1942 by Conrad Waddington, originally defined 
as “The branch of biology which studies the casual interactions between genes and 
their products which bring their phenotype into being” (Waddington, CH., 1942). This 
broad statement encompasses all molecular/biochemical pathways that 
demonstrate the influence on phenotype. Since 1968 a staggering amount of 
research into epigenetics has taken place, as such the term epigenetics has been 
redefined to be “the study of gene changes that are mitotically and/or meiotically 
heritable and that do not entail a change in DNA sequence” (Wu and Morris, 2001). 
In this way, epigenetics demonstrates how all cells of a host organism share 
identical genome, yet the observed phenotypes of specific cell/tissues/organs can 
differ greatly, this is due to the specific gene expression patterns found within 
progenitor cells and their daughter cells (Fessing, 2014). In its loosest term 
epigenetics defines processes which affect gene expression; including post-
replication DNA modifications, non-coding RNAs, RNA post-translational 
modifications, histone modifications, nucleosome positioning, ATP-dependent 
chromatin remodelling and higher order chromatin folding and three dimensional 
(3D) genome organisation (Jaenisch and Bird, 2003, Bintu et al., 2016, Botchkarev 
et al., 2012). 
Chromatin structure has several tiers of structural organisation from the loose 
‘naked’ DNA up to the tightly packaged chromosome seen in cellular metaphase 
(summarised in Fig 1.4a). Chromatin is also a dynamic structure, capable of rapidly 
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shifting from the more open states to the more compacted states and back again. 
DNA is the base form of the physical genome, a sequence of bases connected 
together by a sugar-phosphate backbone, providing the basic genomic sequence of 
the host organism. The next tier is the nucleosome, this is the primary unit of 
chromatin organisation and all additional tiers require nucleosomes. The core 
nucleosome is a DNA-protein complex consisting of 147 bp of DNA wrapped around 
a histone octamer. The histone octamer is composed of two copies of each of core 
histones H2A, H2B, H3 and H4. Core nucleosomes are linked via an additional 
section of linker DNA, which is 20bp - 60bp long (Luger et al., 1997, Kornberg, 1974, 
Khorasanizadeh, 2004, Perdigoto et al., 2014). Chromatin in this state is often 
termed the 10nm fibre or the primary chromatin state; it is also worth noting that 
there are additional histone variants (H2A.X or H2A.Z for example) which are only 
seen in selected nucleosomes. Next, these nucleosomes can be compacted, this is 
due to histone H1 (the linker histone), which binds the linker DNA between 
nucleosomes to the histones, resulting in a change in the overall structure of the 
nucleosome chain. When this occurs the linker DNA may also become inaccessible, 
it is also worth noting that just as with other histones, H1 has several variants, this 
compacted chromatin state is termed the 30nm fibre or secondary chromatin state 
(Harshman et al., 2013). These fibres can then be modelled into loops and stacked 
together anchored to a central chromosome scaffold, this scaffold is not comprised 
of histone based proteins, but scaffold proteins, topoisomerase IIα (TOPO IIα), 
condensin and kinesin family member 4 (KIF4), these proteins are thought to form 
sort of ‘barbers pole’ central to the chromosome axis, although this remains 
uncertain as little is known about the proteins and their distribution (Poonperm et al., 
2015, Samejima et al., 2012). It is worth mentioning that the term ‘chromatin state’ is 
often utilised to mean either the level of spatial chromatin organisation, as has 
previously been described, or can refer to the molecular modifications present on 
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both the DNA or the histones in various regions, the latter has far more 
conformations as there are any number of applicable modifications that may or may 
not be present. 
3D organisation of chromatin is used to describe the spatio/temporal organisation of 
chromatin above the 10nm fibre stage within the nucleus, it has been demonstrated 
that the organisation is not random (Ferrai et al., 2010, Johnston et al., 2019). 
Originally seen only as heterochromatin and euchromatin, densely packaged 
inactive or open and transcriptionally active chromatin respectively, it has since 
been further refined, with heterochromatin being sub divided into constitutive and 
facultative heterochromatin, constitutive heterochromatin is a long term silencing of 
regions not required to be transcribed by the cell, while facultative heterochromatin 
is a more dynamic silencing of genes that may be required during differentiation or 
stress responses (Maison et al., 2010, Murakami, 2019). Further to this, multiple 
experiments, using differing techniques, have demonstrated that chromosomes 
occupy distinct regions of the nucleus, termed chromosome territories (CTs), also 
the positioning of genes within CTs is not random, but based upon positioning of 
other genes and nuclear organelles (Naumova and Dekker, 2010, Sanyal et al., 
2011, Paulsen et al., 2019). Advancements in this area are due to two techniques, 
the first involves confocal microscopy based analysis of nuclei stained with 
fluorescent in situ hybridisation or fluorescent chimeric DNA binding proteins 
(Kumaran and Spector, 2008, Joffe et al., 2010). Or secondly by utilising 
Chromosome Conformation Capture (3C) technologies or its derivatives (4C, 5C 
and hi-C) which involves cross linking chromatin, restriction enzyme digestion, 
ligation, PCR and sequencing to identify spatially contacting regions (Naumova and 
Dekker, 2010). 
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It has been shown that transcriptionally active genes are positioned more closely 
together within CTs, while inactive genes tend to cluster together in silenced regions 
closer to the nuclear periphery. A process involving several chromatin architectural 
proteins (Satb1, Satb2, cohesin  and CTCF to name a few) as well as ATP-
dependent chromatin remodelling complexes (ISWI, SWI/SNF, NuRD etc.) acting in 
concert to facilitate the opening of specific genomic regions and manoeuvring the 
region to within range of specific promoters or enhancers, in order to activate and 
repress gene expression. A good example of this is the epidermal Differentiation 
Complex (EDC) locus, a gene dense stretch of DNA encoding several dozen genes 
required for terminal epidermal differentiation. Studies have shown that the EDC loci 
is moved during epidermal progenitor cell maturation, taken from an area of gene 
silencing to an area of transcriptional activation, this remodelling is facilitated by 
p63, Brg1 and Satb1, as a loss of either results in epidermal differentiation defects 
(Fessing et al., 2011, Mardaryev et al., 2014). 
1.4.2 Covalent DNA modifications 
DNA methylation is a modification seen on the DNA of most eukaryotic organisms, 
however the methylation pattern differs between species or subphylar. For example 
Saccharomyces cerevisiae and the nematode worm Caenorhabditis elegans have 
no DNA methylation, while some fungi only methylate DNA repeats, invertebrates 
tend to have a mosaic methylation pattern, with regions of extensive methylation 
interspersed with methylation free zones (Suzuki and Bird, 2008, Liu et al., 2019a, 
Kvist et al., 2018). The focus here however will specifically be mammalian DNA 
methylation patterns. 
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In mammals DNA methylation is a modification resulting in the addition of a methyl 
group to C5 position of cytosine, giving 5’-methylcytosine (5mC) (shown in Fig 1.4b), 
this modification occurs most predominantly at CpG dinucleotides (where cytosine is 
adjacent to guanine), with up to 70% of all CpG sites modified (Jones, 2012, Rivas 
et al., 2019). One exception however are the short regions (1-2kbp) with high CpG 
density (termed CpG islands) which remain largely unmethylated. CpG islands are a 
common feature found at the promoter sites or in the first introns of housekeeping 
genes (Reik, 2007, Wang and Kadarmideen, 2019). Interesting however is the 
methylation of the so called CpG island shores, these are located approximately 
2kbp from transcriptional start sites (TSS) of CpG island containing gene promoters 
and are methylated in a differentiation specific manner (Feng et al., 2010). 
In mammals maintenance of DNA methylation is carried out by DNA 
methyltransferase 1 (DNMT1), which is capable of transferring a methyl group from 
a methyl donor S-adenosyl-L-methionine (SAM) to the cytosine base, during 
replication methylation status is not transferred to the daughter strand, and so DNA 
is hemi-methylated, DNMT1 recognises these hemi-methylated sites and restores 
the methylation state on the newly synthesized strand (Feng et al., 2010, Jimenji et 
al., 2019). While DNMT1 carries out maintenance, de novo methyltransferases 3l, 
3a and 3b (DNMT3l and DNMT3a/3b) are responsible for establishing the 
methylation pattern of cells during embryonic development, and in adult stem cells 
(Feng et al., 2010), DNMT3l lacks the enzymatic activity, but instead associates with 
DNMT3a/3b to fulfil its role. 
DNA methylation is commonly associated with gene repression, methylated sites 
inhibit binding of transcription factors, methylated sites may also be targeted by 
repressive chromatin remodelling complexes, preventing access to the gene (Reik, 
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2007). However, there are some cases in which DNA methylation may actually 
result in active gene transcription (Rishi et al., 2010). 
DNA methylation has been shown to be vital to survival, mice deficient in DNMTs 
die either embryonically or shortly after birth. Interestingly, a loss of DNMT1 results 
in early embryonic death, with lethality occurring at E9.5 (Li et al., 1992, Han et al., 
2019), while loss of DNMT3a showed the longest life with death at approximately 4 
weeks postnatally (Okano et al., 1999). DNA methylation also plays a vital role in 
epidermal development, elevated levels of DNMT1 are seen in basal keratinocytes 
and loss of DNMT1 showed premature differentiation, loss of proliferation and the 
progenitor state in human basal keratinocytes (Sen et al., 2010). As previously 
mentioned while 5mC is associated with repression it has been shown to have 
functions in transcriptional activation, specifically by recruiting CCAAT/enhancer 
binding protein α (C/EBPα). C/EBPα is an important transcription factor in epidermal 
differentiation and is predominantly expressed in suprabasal layers, a loss of 
C/EBPα results in a basal layer hyperplasia, loss of differentiation and increased 
apoptosis in the suprabasal layer (Oh et al., 2007, Rishi et al., 2010, Marthaler et al., 
2017). 
Recently, a new DNA modification was found in mammals, or rather a modification 
of DNA methylation, oxidation of the methyl group in 5’-methylcytosine results in the 
formation of 5’-hydroxymethylcytosine (5hmC), shortly after its finding the ten-eleven 
translocation (TET) family of proteins was seen to cause this oxidation to occur. The 
TET family has 3 members (TET1, TET2 and TET3) and while it was initially seen in 
TET1, TET2 and TET3 were also confirmed to be able to oxidise 5hmC (Tahiliani et 
al., 2009, Ito et al., 2010, Ko et al., 2010, Liu et al., 2019b). Interestingly, 5hmC 
distribution in the genome is distinct from 5mC, and likely demonstrates that 5hmC 
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has its own functionality, for example 5hmC is seen at elevated levels in mouse 
embryonic stem cells, which may suggest it has a role in maintaining stem 
properties (Xu et al., 2011, Wu and Zhang, 2011b), although the primary role of 
5hmC is thought to be as an intermediary during DNA demethylation. Currently 
there are two DNA demethylation mechanisms which have been identified; one 
possibility is that hemi-hydroxymethylated DNA is not recognised by DNMT1 and so 
the daughter strand is not re-methylated post replication resulting in a passive 
replication dependant DNA demethylation (Inoue and Zhang, 2011), another 
possibility is due to the TET proteins ability to further oxidate 5hmC to form 5’-
formylcytosine (5fC), and further still to 5’-carbxycytosine (5caC) (Branco et al., 
2012), which may be removed by thymine DNA glycosylase (TDG), which has been 
shown to activate the base excision repair (BER) pathways to correct thymine to 
guanine (T:G) mismatch events, interestingly TDG will preferentially bind 5fC over 
T:G mismatch sites (Branco et al., 2012, Maiti and Drohat, 2011). The BER pathway 
would then insert an unmethylated cytosine, suggesting this is a likely pathway in 
rapid demethylation (possible mechanisms are summarised in Fig 1.4c). 
1.4.3 Covalent histone modifications 
As previously mentioned the nucleosome consists of DNA wrapped around a 
histone octamer. These histone molecules could be modified in numerous ways. 
Most often the N-terminal tails are  modified, these modifications include acetylation, 
methylation, phosphorylation, ubiquitination, sumoylation, deamination and several 
others (Perdigoto et al., 2014). The type of modification and location of said 
modification will determine the effect on gene transcription, and the chromatin state 
itself as these modifications are able to alter histone-DNA and histone-histone 
interactions, and so facilitate access to genes by transcriptional machinery 
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(Perdigoto et al., 2014, Ikeuchi et al., 2015) (some histone marks are shown in Fig 
1.4d). The modifications of the histones are termed histone marks, and each mark 
correlates with a specific effect, for example H3K4me3 denotes that histone 3, lysine 
residue 4 is tri-methylated, this is a very common mark and is associated with 
transcriptional activation (Guenther et al., 2007, Li et al., 2018). 
Histone acetylation and methylation are the most well characterised modifications, 
methylation is associated with both transcriptional activation and repression, while 
acetylation is more commonly linked with activation, specific enzymes carry out the 
acetylation or methylation (or any of the other modifications) of histones, these are 
histone acetyltransferases (HATs) or histone methyltransferases (HMTs), their 
counterparts are histone deactylases (HDACs) and histone demethylases (HDMTs) 
which remove the acetyl or methyl group respectively (Qadir and Anwer, 2019).   
1.4.3.1 Histone acetylation 
Acetylation state of lysine residues on histone tails determines transcriptional effect, 
by influencing histone-DNA interactions, acetylation of lysine residues is regulated 
by 2 opposing groups of enzymes, HATs and HDACs. Histone hyper-acetylation is 
associated with activating gene transcription, while hypo-acetylation is associated 
with gene repression, due to changes in chromatin compaction and recruitment of 
bromo-domain containing proteins (Campos and Reinberg, 2009). Specific histone 
marks are associated with specific transcription responses, interestingly the histone 
marks seen at a promoter region differ from the marks seen at the gene coding 
region of active genes, for example, active promoters are enriched with histone 
marks H3K9ac, H3K18ac and H2B12ac, while H4K12ac and H4k16ac are seen 
broadly in many gene coding regions (Botchkarev et al., 2012) 
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Acetylation marks in epidermal development have been associated with promoting 
proliferation, and inhibiting differentiation, by using HDAC inhibitor triclostatin A 
(TCA) on primary keratinocytes results in a cell cycle arrest and expression of 
involucrin (a differentiation marker), loss of both HDAC1 and HDAC2 also results in 
epidermal stratification failure (Markova et al., 2007, LeBoeuf et al., 2010). Within 
hair follicle stem cells histone 4 is hypo-acetylated, however after c-Myc mediated 
release from the stem cell niche, elevated acetylation of histone 4 was seen 
(Botchkarev et al., 2012, Frye et al., 2007). 
1.4.3.2 Histone methylation 
Histone methylation is regulated by HMTs and HDMTs; histone methylation differs 
slightly from acetylation as methylation can be one of three types, mono-, di- or tri-
methylation, denoting the number of methyl groups attached to a single amino acid 
residue. As with acetylation specific methylation marks denote transcriptional 
activation or repression. Interestingly, histone methylation is associated with both 
activation and repression, as histone tails can be mono-, di-, or tri- methylated there 
is a complex relationship between level of the histone methylation and 
transcriptional response, generally di- or tri-methylated lysine residues result in 
transcriptional repression, H3K9me2/3, H3K27me3 and H4K20me3 (Wang et al., 
2009), while mono-methylated lysine residues are more likely to be associated with 
activation, with the notable exception of H3K4me3, which is seen at active TSS sites 
and genes with a paused RNA polymerase II (RNA POL II), meanwhile H3K4me1/2 
are found near TSS of active genes and in gene enhancers (Barski et al., 2007, 
Wang et al., 2009, Botchkarev et al., 2012).  
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Histone methylation during epidermal development has been investigated in more 
detail, specifically the marks H3K20me1 and H3K27me3. H3K20me3 are catalysed 
by setd8-mediated histone methylation and is found at active transcription sites, a 
loss of Setd8 results in a loss of proliferation and abnormal differentiation of the 
epidermis (Driskell et al., 2011). Histone mark H3K27me3 is associated with 
repression, and is found at the TSS of many epidermal genes, to remove this 
repressive mark and allow epidermal differentiation the Jumonji C domain containing 
protein D3 (JMJD3) is required; JMJD3 is a demethylase specific to H3K27me3, and 
a loss of JMJD3 results in failed epidermal differentiation (Sen et al., 2008). 
1.4.4 Polycomb repressive complexes 
The activity of repressive mark H3K27me3 is mediated by polycomb group proteins 
(PcGs), this group of proteins is able to block RNA POL II activity by compacting 
chromatin (Di Croce and Helin, 2013). PcGs form larger complexes, the polycomb 
repressive complexes (PRCs), there two major families of PRC (PRC1 and PRC2), 
both act to compact chromatin and repress gene expression, and are vital to 
development, as well as maintaining stem cell potential (Simon and Kingston, 2009). 
PRC1 has two major variants, canonical PRC1 is comprised of four core PcGs; 
RING1, CBX, PCGF and PHC, while non-canonical PRC1 contains only 3 PcGs 
RING1, PCGF and RYBP (Gao et al., 2012), it is also worth noting that all 
mammalian PcGs involved in PRCs have multiple homologs (Chen and Dent, 2014). 
PRC2 contains three PcGs; EZH, EED and SUZ21, it is also likely that additional 
proteins are incorporated into PRCs (Botchkarev et al., 2012, Plys et al., 2019).  
PRC mediated transcriptional repression is proposed to be via one of several 
mechanisms. Firstly there is PRC2 mediated methylation of H3K27, which is 
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targeted by Cbx4 (PRC1), and subsequently PRC1 carries out ubiquitination of 
H2AK119 (H2AK119ub), compacting chromatin and preventing access to gene 
promoters (Lee et al., 2007, Hammond-Martel et al., 2012). Secondly, PRCs may 
bind to RNA POL II complexes, preventing elongation and producing short RNA 
transcripts which are then degraded (Fachinetti et al., 2010). Finally, PRCs act as a 
chromatin remodelling complex, which are capable of creating ‘repressive hubs’ or 
clusters of genes in densely packed chromatin regions (Bantignies and Cavalli, 
2011). Each of these possibilities are further explained below. 
The PcG protein EZH, a core subunit of PRC2, has two homologs; EZH1 and EZH2, 
both of which are HMTs which are highly specific to H3K27, EZH1/2 is able to 
mono-, di- or tri-methylate H3K27 (Yoo and Hennighausen, 2012, Son et al., 2013), 
however EZH1/2 is unable to carry out its function as a methyltransferase without 
EED and SUZ12 (Cao and Zhang, 2004, Suh et al., 2019). Several additional 
proteins have been linked with recruitment of PRC2, for example adipocyte 
enhancer-binding protein 2 (AEBP2), a zinc-finger binding protein, was shown to 
bind DNA and recruit PRC2 (Kim et al., 2009). Moreover,  the TET proteins may be 
involved due to their role in modifying 5mC (Wu and Zhang, 2011a), as well as a 
member of the Jumonji C domain containing protein family, JARID2, is capable of 
not only enhancing PRC2 recruitment but also in maintaining homeostasis (Son et 
al., 2013, Li et al., 2010). 
The repressive mark H3K27me3 is recognised by Cbx4, a member of the canonical 
PRC1, this is because H3K27me3 is a recognised by the CHROMO-domain of 
Cbx4, once bound the RING1/2 protein catalyses the ubiquitination of H2AK119, 
driving chromatin compaction, which prevents the binding of transcription machinery 
and ATP-dependent chromatin remodelling complexes, namely SWI/SNF. 
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(Hammond-Martel et al., 2012, Bantignies and Cavalli, 2011). In vitro studies have 
also demonstrated that H2AK119ub prevents the methylation of H3K4, however 
H2AK119ub is required to reverse PRC mediated gene silencing, as the 
H2AK119ub mark is a target of zuotin-related factor 1 (ZRF1), which is able to 
remove PRC1 from chromatin and activate gene transcription (Richly et al., 2010). 
It was previously thought that the repressive capability of PRCs was a result of the 
H3K27 methylation by PRC2, leading to recruitment of PRC1. However, the 
discovery of the non-canonical PRC1 called this into question, as H3K27me3 
mediated recruitment of PRC1 requires the Cbx PcG, which is not present in the 
non-canonical PRC1 (Zhen et al., 2014, Bae and Hennighausen, 2014). Additionally, 
some CpG islands have been shown to be able to recruit both PRC1 and PRC2 by 
specific mechanisms (Wu et al., 2013, Riising et al., 2014). It has also been 
demonstrated that a non-canonical PRC1 protein KDM2B facilitates non-canonical 
PRC1 targeting by binding to CpG rich DNA, specifically involving the zinc-finger 
domain CXXC. KDM2B was found at the unmethylated CpG islands in mouse 
embryonic stem cells (mESCs) (Wu et al., 2013). Tet proteins might also have a role 
in PRC2 recruitment (Wu and Zhang, 2011b) demonstrated that in mouse 
embryonic stem cells Tet1 and 5hmC were enriched at bivalent gene promoter 
marked with repressive histone marks H3K4me3 and H3K27me3, and the depletion 
of Tet1 impaired recruitment of EZH2. Interestingly, it has been shown that the non-
canonical PRC1 is able to recruit PRC2 via H2AK119ub. Moreover, AEBP2 and 
JARID2 associated PRC2 are present in nucleosomes containing the H2AK119ub 
modification, where they facilitated methylation of H3K27 (Blackledge et al., 2014, 
Kalb et al., 2014), demonstrating a complex relationship between PRC1 and PCR2 
capable of recruiting each other to facilitate transcriptional silencing. 
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The role of PRC2 in epidermal development has been investigated using mouse 
models; analysis of the H3K27me3 mark in basal epidermal cells has shown it to be 
present on several thousand genes associated with neuronal, muscle and 
hematopoietic cell differentiation. Genes involved in early epidermal differentiation 
did not contain the H3K27me3 mark; however it was seen at genes controlling late 
stage differentiation and normally expressed in granular and cornified cells (Ezhkova 
et al., 2009). EZH2 was highly expressed in the proliferative basal layer, but was 
down-regulated in differentiated suprabasal cells, knockdown of EZH2 in basal cells 
resulted in accelerated development of the epidermal barrier, irregular hair follicle 
formation and upregulation of genes associated with epidermal differentiation, 
specifically those of the EDC (Ezhkova et al., 2009, Bardot et al., 2013). EZH2 
mediated silencing of the epidermal differentiation programme was achieved via 
preventing binding of AP1, a key transcription factor driving epidermal differentiation. 
Ablation of either of the other PRC2 subunits (EED or SUZ12) results in a similar 
phenotype (Conway et al., 2015). Interestingly, the postnatal ablation of any of the 
PRC2 subunits showed no loss of proliferation in the epidermal progenitor cells 
(EPCs) in skin, but did show a loss of proliferation in the EPCs of the hair follicle 
(Dauber et al., 2016). This suggests that PRC2 loss can somehow be mitigated, it is 
currently thought to be due to the cell niche rather than other intrinsic properties as 
simultaneous Ezh1 and Ezh2 ablation in cell culture shows equal effects on EPCs 
regardless of their origin site (Ezhkova et al., 2011, Wassef et al., 2019). Further 
investigation into the cell micro-environment is required to identify the specific 
mechanism at work in mitigating the loss of PRC2 in basal layers of epidermis 
(Botchkarev and Mardaryev, 2016). 
CBX4, a component of the canonical PRC1 has also been shown to play a role in 
epidermal proliferation and differentiation. CBX4 contains a SUMO E3 ligase 
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activity, which is able to facilitate sumoylation of proteins, including DNMT3a, 
demonstrating a link between PRC repression and DNA methylation (Li et al., 
2007a, Li et al., 2007c, Mohamad Hanif and Shah, 2018). CBX4 is seen to regulate 
epidermal differentiation in two ways, firstly by preventing senescence in epidermal 
progenitor cell via PRC mediated repression of the INK4a locus, and secondly by 
promoting differentiation via non PRC mediated mechanisms (Luis et al., 2011). 
More recently, it has been shown that CBX4 is a direct target of epidermal master 
regulator p63, the two works in concert to promote epidermal differentiation while 
repressing non-epidermal lineage genes (Mardaryev et al., 2016). 
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Figure 1.4 Chromatin structure, DNA modifications and Histone post transcriptional 
modifications
a) Chromatin organisation levels, from the DNA double helix to the metaphase 
chromosome. b) Schematic of DNA methylation, and subsequent oxidation to 
generate 5’-hydroxymethylcytosine. c) Proposed mechanisms of demethylation 
utilising TET family proteins. d) Common histone post-transcriptional modifications. 
Images adapted from (Luo et al., 2011, (Yang et al., 2013, Song et al., 2012), song 
et al, 2012, Fortress and Frick, 2015) 
  
 47 
 
1.4.5 ATP-dependent chromatin remodelling  
1.4.5.1 Overview of ATP dependent chromatin remodelling 
ATP-dependent chromatin remodelling complexes (CRCs) are large multi 
component complexes at over 1MDa in size and vary in the number of components, 
all CRCs contain an ATPase subunit which belongs to the superfamily II helicase 
group (SF2) as well as possessing DExx and HELICc regions separated by a linker 
region (Bao and Shen, 2007, Barisic et al., 2019). The size of this linker region and 
additional domains can be used to divide CRCs into four families; SWI/SNF, ISWI, 
NuRD/Mi-2/CHD and INO80. Members of the SWI/SNF family contain a HSA 
(helicase SANT associated) and a BROMO region that facilitates the binding to actin 
or acetylated lysine residues of histone tails respectively. The ISWI family contains a 
SANT and SLIDE region that are required for histone binding. The NuRD/MI-2/CHD 
family contains tandem CHROMO domains which is also required for histone 
binding. Finally, The INO80 family also contains a HSA region similar to that seen in 
the SWI/SNF family but not the BROMO region, INO80 are also the only family to 
have larger linker region between the DExx and HELICc regions. While some 
families are associated more with one specific function, there is no evidence to 
suggest that each family fulfils a single role, as there are multiple families and sub-
families the possibility of synergistic or antagonistic effects between different 
families exists. CRCs work by weakening the interactions between histones and 
DNA, an ability derived from the energy obtained through ATP hydrolysis. Disrupting 
these interactions allows nucleosome switching, sliding or ejection (Saha et al., 
2006, Weinhouse et al., 2018). However, the exact mechanism of action undertaken 
by CRCs is currently unknown, one of the most likely mechanisms is detailed in the 
‘loop model’, this involves the generation of a DNA loop caused by the CRC pushing 
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DNA from the linker section onto the histone core which results in a breaking of 
histone/DNA bond, this loop then propagates around the histone, resulting in access 
to the DNA, or the ability to eject, slide or switch the histone, several subunits are 
thought to be involved in this process, ensuring loop propagation occurs in one 
direction, or as nucleosome chaperones or facilitating the switch of histone core 
units (Ludwigsen et al., 2013, Nodelman and Bowman, 2013). 
The focus here will be on the SWI/SNF family, specifically the mammalian variant, 
which is also known as mSWI/SNF or BAF complex (BRG1 Associated Factors or 
hBRM Associated Factors), and the highly similar PBAF complex (Polybromo BRG1 
Associated Factors). 
1.4.5.2 SWI/SNF chromatin remodelling complexes and their role in early 
embryonic development  
The SWI/SNF complex was originally discovered in yeast after 2 independent 
studies into mutations affecting mating type switching and sucrose non-fermenting 
pathways, swi and snf. These genes encoded proteins capable of interacting with 
histones and chromatin, it was later discovered that they were subunits of a much 
larger multicomponent complex, the complex was named SWI/SNF after the genes 
leading to its discovery (Sudarsanam and Winston, 2000). The SWI/SNF complex is 
highly conserved between species; however the exact composition of the complex is 
changed slightly. The increased genome size and complexity of higher eukaryotes 
has resulted in expanded gene families rather than single genes encoding different 
subunits (e.g. swp73is present in yeast, while BAF60a, b, and c are the human 
counter parts).  
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Later a similar chromatin remodelling complex was discovered in yeast, this 
remodeller was named RSC (remodelling the structure of chromatin) (Cairns et al., 
1994). RSC shares homology with many subunits of SWI/SNF, as well as a similar 
function in nucleosome remodelling, however RSC is seen at much higher levels 
than SWI/SNF, suggesting a more vital role (Cairns et al., 1996), It was later 
discovered that Sth1 (a subunit of the RSC complex) was required for yeast cell 
viability.(Treich and Carlson, 1997) 
Mammalian SWI/SNF has two variant complexes, BAF and PBAF, which are almost 
identical in component composition, with very few components being exclusive to 
one or the other. All components of the BAF and PBAF complex are reported to 
interact with all or part of the nucleosome; each subunit contains one or more 
domains which specifically interact with, histones, histone tail residues or DNA, with 
each subunit providing a specific binding region or enzymatic activity. This 
multicomponent aspect suggests a vast array of possible functions determined by 
the specific subunit composition of the BAF/PBAF complexes, which is utilised to 
facilitate a particular task, rather than single ‘all-purpose’ complex. Due to the 
differences in subunit composition there is no single ‘BAF complex’ but rather a 
multitude of BAF complexes. 
The BAF complex is made up of several core subunits, as well as a number of 
associated proteins. This has led to disagreements in what makes up the complex, 
and what should be termed a subunit or associated protein. Here I will mainly 
discuss subunits, and I will define these as proteins with functionality directly linked 
to the SWI/SNF complex, or with evolutionally conserved homology within the 
SWI/SNF complex. Proteins involved in SWI/SNF complex but with common 
functionality outside of the complex (i.e. β-actin) will be referred to as associated 
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proteins. Additionally, I will use the term constitutive to define those subunits 
repeatedly reported to be present in SWI/SNF complexes, while the term facultative 
will be applied to subunits, which are not reported to be present in all explored 
SWI/SNF complexes. 
The BAF complex is generally considered to be made up of 5 constitutive subunits, 
and several facultative subunits. The constitutive subunits include an ATPase core, 
either SMARCA4/BRG1 or SMARCA2/hBRM, which are mutually exclusive in a 
single complex; the remaining constitutive subunits are ARID1a/BAF250a or 
BAF250b (mutually exclusive in a single complex) and SMARCC2/BAF170, 
SMARCC1/BAF155 and INI1/hSNF5/BAF47 (Wang et al., 1996, Lessard et al., 
2007). The number of facultative subunits is still being debated (due to different 
criteria being used to determine subunit or associated protein) currently the total 
maximum number of subunits found within a BAF complex is 19, and approximately 
2-MDa in size of complex (Ronan et al., 2013), any of which may or may not be 
present depending on the cell/tissue type and developmental stage. The PBAF 
complex is nearly identical to BAF, with few exceptions, PBAF shares most of the 
same constitutive subunits (SMARCC2/BAF170, SMARCC1/BAF155 and 
INI1/hSNF5/BAF47) but does not contain either ARAID1a/BAF250a or 
ARID1b/BAF250b, instead PBAF contains core subunits ARID2/BAF200 and 
PBRM/BAF180/polybromo, PBAF also exclusively contains SMARCA4/BRG1 as the 
ATPase subunit. The facultative subunits are also largely the same, although 
different isoforms of some subunits have been identified exclusively in PBAF (Yan et 
al., 2005, Brownlee et al., 2012, Brechalov et al., 2014). 
The ATPase subunit of the BAF complex (SMARCA4/BRG1 or SMARCA2/hBRM) 
contains the DExx and HELICc regions common to all SWI/SNF super-family 
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members (Lusser and Kadonaga, 2003, Singleton and Wigley, 2002, Clapier et al., 
2017). Both also contain the HSA (Helicase SANT associated) region, which serves 
as a platform for the binding of nuclear actin-related proteins (ARPs), β-actin or 
actin, this also serves to bind another component BAF53 (Szerlong et al., 2008). 
BRG1 and hBRM also contain a bromo-domain required for binding acetylated 
lysine residues; these domains facilitate recognition of the nucleosome target 
(Haynes et al., 1992, Zeng and Zhou, 2002, Morrison et al., 2017), where acetylated 
histone tails are generally associated with transcriptionally active sites.  
BRG1 and hBRM share approximately 75% homology, however they play non-
redundant roles during embryonic development .Brg1 -/- mouse embryos fail to 
correctly implant, or terminate at the time of implantation, while brm -/- mice are both 
viable and fertile, with only a few mild changes, namely dysregulation of the 
fibroblast cell cycle and a larger size compared to the wild type littermates (Bultman 
et al., 2000, Reyes et al., 1998, Thompson et al., 2015). Other studies have shown 
that at later stages and in some cell types either BRG1 or BRM can compensate for 
a loss of the other (Strobeck et al., 2002, Xue et al., 2000, Hoffman et al., 2014, 
Raab et al., 2017), or even have antagonistic roles (Flowers et al., 2009). These 
studies support that BRG1 and BRM serve as ‘engines’ which only drive the 
remodelling machinery, while the specific accessory components provide specific 
targeting and functionality.  
All variants of BAF or PBAF complex are simply termed BAF or PBAF, however it 
has been demonstrated previously that BAF complexes can be specific to 
cell/tissue/stage of development. While there are few validated examples (detailed 
below and summarised in Fig 1.5), in the future I expect BAF/PBAF complexes will 
be identified as unique in almost all tissues at one stage or another, which may also 
prove invaluable to the reprogramming induced pluripotent stem cells. 
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Embryonic stem cell specific BAF complexes (esBAF) have been described in 
mouse models, and are shown to regulate pluripotency and maintain cell stemness. 
esBAF has also been shown to interact directly with pluripotency factors, Oct4, 
Sox2, Nanog etc. (Ho et al., 2009, Panamarova et al., 2016, Alfert et al., 2019). The 
composition of esBAF is so far unique and has not been seen elsewhere, esBAF 
complex contains BRG1, and a homodimer of BAF155, while BRM and BAF170 are 
not seen in esBAF. Loss of either BRG1, BAF155 or BAF47 at the preimplantation 
stage result in lethality (Klochendler-Yeivin et al., 2000, Kim et al., 2001, Cabot et 
al., 2017), supporting their crucial role in cell survival and viability. 
BAF45a, BAF53a and BAF60a/b are also seen in esBAF, as well as in other 
progenitor cell types, suggesting these specific family members are required to 
maintain the progenitor states (Zhang et al., 2019, Panamarova et al., 2016). 
While the component composition of esBAF is not unique to either BAF or PBAF 
complexes, it has also been demonstrated that PBAF is not involved in maintaining 
the ESC state, as a loss of BAF180 showed no effect on the stemness of ESCs 
(Wang et al., 2004). 
Another tissue specific BAF complex is seen in cardiac progenitor cells, cardiac BAF 
(cBAF) is not yet fully characterised, however it is known the BAF60c is specifically 
required (Lickert et al., 2004, Takeuchi and Bruneau, 2009, Sun et al., 2018). 
Interestingly, cardiac development also requires BAF250b (Lei et al., 2012), which is 
specific to BAF and not to PBAF, however BAF180, which is specific to PBAF, is 
also required for cardiac maturation (Wang et al., 2004, Huang et al., 2008). As a 
result a, loss of either component results in lethal heart defects during murine 
embryogenesis, supporting that required complexes are stage dependent. A recent 
study has also shown that BAF60a knockout in embryonic stem cells caused a 
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redistribution of H3K27me3 marks on chromatin, which may indicate interactions 
with the PRCs (Alajem et al., 2015). 
1.4.5.3 Defects in SWI/SNF complexes in cancer 
BAF/PBAF complexes cannot be discussed without talking about their role in 
cancer, for example BAF47 was originally discovered to have a role in cancer and 
was later discovered to be a bona fide tumour suppressor (Versteege et al., 1998, 
Biegel et al., 1999), since then the cancer spotlight has been on BAF/PBAF 
complexes and it estimated that 20% of all human cancers are associated with the 
mutated BAF/PBAF subunits (Kadoch et al., 2013, Arnaud et al., 2018). 
Almost all BAF/PBAF subunits and associated proteins are linked to cancer, which 
is unsurprising when you consider the role of the BAF/PBAF complexes in regulating 
cellular processes including; chromatin organisation, control of gene transcription, 
DNA repair pathways and cell cycle control. This has led to the BAF/PBAF 
complexes becoming the focus for the development of new anticancer drugs 
(Farnaby et al., 2019). 
Tumours associated with a loss of BAF/PBAF complex subunit mutations often 
result in specific tumour types dependent upon which subunit is mutated. For 
example a biallelic loss of BAF47 results in rhabdoid tumours (Eaton et al., 2011), 
while BRG1 mutations are associated with small cell carcinoma, hypercalcaemic 
type (SCCOHT) (Jelinic et al., 2014). 
There are several excellent reviews on BAF/PBAF complex association with cancer 
(Hohmann and Vakoc, 2014, Helming et al., 2014, Shain and Pollack, 2013).  
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1.4.5.4 SWI/SNF complexes and epidermal and hair follicle biology 
The role of BRG1 during epidermal development is well established, a systemic loss 
of BRG1 results in lethality at the peri-implantation stage (discussed previously), 
epidermal specific ablation of Brg1 in mice revealed its crucial role in limb and 
epidermal barrier development (Indra et al., 2005). This study demonstrated that 
Brg1 is required to facilitate terminal differentiation of keratinocytes and adequate 
barrier formation, but not for maintaining proliferation or early stages of keratinocyte 
differentiation. A later study demonstrated that BRG1 is a direct target of p63, and is 
required to relocate the EDC from the nuclear periphery into the more 
transcriptionally favourable nuclear interior, which facilitates transcriptional activation 
of the EDC, giving rise to fully differentiated corneocytes and adequate barrier 
formation (Mardaryev et al., 2014). It has also been shown that BAF and p63 co-
regulate over 200 genes specific to the epidermal lineage and their co-expression is 
mutually required to maintain an open chromatin landscape enabling epidermal 
differentiation (Bao et al., 2015). 
ACTL6a/BAF53a has also been implicated in epidermal development by modulating 
the BAF complex activity, preventing its binding to the KLF4, as well as other 
keratinocyte specific gene promoter regions, preventing their activation, maintaining 
the epidermal progenitor state and preventing premature keratinocyte differentiation 
(Bao et al., 2013). It was also demonstrated that epidermis specific knockout of 
BAF53a abolished the epidermal progenitor state, resulting in terminal differentiation 
and tissue loss. The activity of BAF53a was also demonstrated to be directly due to 
its interaction with BAF complexes and in turn the KLF4 transcription factor (Bao et 
al., 2013). This data also supports that BAF subunits have a regulatory role over the 
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complex itself, and do not simply act as targeting molecules, which may also 
suggest the role of some subunits is entirely to regulate the complex itself. 
BRG1 has also been shown to effect hair follicle homeostasis. Hair follicle stem cells 
are located in the bulge region and are utilised in both epidermal wound healing and 
regeneration of the hair follicle during hair cycling. It has been demonstrated that 
Brg1 is indispensable to the maintenance of the murine hair follicle stem cell 
reservoir, as well as facilitating their activation during anagen induction and the 
cutaneous wound healing response (Xiong et al., 2013). This effect is part of a 
reciprocal feedback loop between Brg1 and Shh, by which Shh signalling activates 
Brg1 via Gli1 transcription factor, to regenerate the follicle during cycling, while Brg1 
helps to recruits NF-κB to activate Shh gene transcription to maintain hair matrix cell 
proliferation. The murine hair follicles stem cell specific Brg1 ablation results in an 
inhibition in hair matrix cell proliferation and differentiation as well as the gradual 
loss of the hair follicle stem cell reservoir (Xiong et al., 2013). 
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Figure 1.5 Chromatin remodelling complexes and cell specific SWI/SNF complexes
Examples of cell type specific BAF/PBAF complexes, as well as some of the 
signalling pathways involved with their regulation. (Image adapted from Ho and 
Crabtree, 2010) 
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1.5 Epidermal regeneration during skin wound healing 
A cutaneous wound is a break in the epidermis and underlying dermis; this could be 
any kind of lesion, burn or tear in the skin, resulting in a loss of its integrity and 
disruption of the underlying structure and function. This loss in the protective barrier 
must be corrected rapidly to ensure homeostasis is resumed, a healed wound is one 
in which connective tissue have been restored and re-epithelialisation has occurred 
(Rittie, 2016). 
One of the key issues in epidermal wound healing research is that clinically a wound 
is any rupture in the skins continuity, as such minor lesions replicated in the lab may 
not recapitulate the large scale lacerations which could fully penetrate the flesh and 
muscle beneath, however a base understanding of the mechanisms involved will 
hopefully translate into improvements in all clinical applications in cutaneous wound 
healing. 
1.5.1 Skin wound healing process overview 
Wound healing is usually divided into three phases; inflammation, proliferation and 
remodelling. These are not linear events however, they overlap over time until the 
wound is healed (shown in Fig 1.6a) (Reinke and Sorg, 2012).  My primarily focus 
will be on wound closure and re-epithelisation.  
1.5.1.1 Keratinocyte proliferation, migration and differentiation during skin 
wound healing 
Skin  wound healing process is highly dependent upon the size, location and depth 
of the wound, all of which can drastically affect the time taken to reach the 
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proliferation phase, as well as the length of time the proliferation phase continues for 
(Shaw and Martin, 2009). Within mammalian species wound healing relies primarily 
upon the activation, migration and differentiation of inter-follicular epidermal 
keratinocytes and HF stem cells (Plikus et al., 2012). 
Re-epithelisation of a wound by keratinocytes is carried out by a combination of 
migration and proliferation of keratinocytes in close proximity to the wound edge 
(Martin, 1997, Shaw and Martin, 2009). Basal keratinocytes at the edge of the 
wound proliferate and move as a collective ‘sheet’ across a provisional ‘wound 
healing matrix’ prepared during the inflammation stage. In order for the 
keratinocytes to migrate a series of modifications must take place. These 
modifications begin with modifying their cell-cell/cell-matrix attachments, loosening 
the tight bonds holding them in place (Nguyen et al., 2000). Then the formation of 
actin rich lamella protrusions which are required for ‘crawling’ (Mitchison and 
Cramer, 1996), as well as the upregulation of proteolytic enzymes, 
metalloproteinases (MMPs) which specifically degrade type-IV collagen found in the 
basement membrane allowing cells to detach and migrate and facilitates penetration 
of the interface between scab and viable tissue (Pilcher et al., 1999). Migrating 
keratinocytes secrete laminin V to facilitate regeneration of the basement 
membrane. At the forefront of the migrating wound ‘tongue’ keratinocytes continue 
to proliferate, these cells are hypertrophic and produce similar actin rich lamella 
protrusions to maintain migratory directionality (Coulombe, 1997). Additionally, 
during migration new cytoskeletal filaments are expressed, namely K6, K16 and 
K17, while differentiation-associated keratins (K1/K10) are down-regulated 
(Wawersik et al., 2001, Myers et al., 2007). However, the expression of these 
keratins require proper regulation as the overexpression of K16 results in epidermal 
lesions (Coulombe et al., 1995). As a wound is a three dimensional structure the 
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migrating keratinocytes are converging on a single point in the centre, furthest from 
any healthy tissue, when migrating keratinocytes meet contact inhibition occurs, 
halting the progress and establishing a new basement membrane, keratinocytes 
then begin to differentiate, shutting down the K6, K16 and K17 expression and re-
establishing normal differentiation and stratification pathways, beginning at the 
wound edge and gradually encroaching on the centre of the wound (Broughton et 
al., 2006, Li et al., 2007b). 
Migration of keratinocytes is regulated by a series of transcription factors, which are 
seen to be upregulated at the wound edge. These factors include AP-1 components, 
c-JUN and c-FOS. A loss of c-JUN has previously been shown to delay wound 
healing in mice, and a loss of Nuclear hormone receptor co-activator (NRC), a co-
activator of c-JUN and c-FOS results in development of chronic wounds (Mahajan et 
al., 2004, Schafer and Werner, 2007). 
1.5.1.2 Epidermal and hair follicle stem cell activation  
It is well established that wounds in regions with an abundance of hair follicles heal 
faster than regions lacking hair follicles (Stojadinovic et al., 2011). Mice wounded 
during anagen phase of the hair cycle heal faster than in telogen phase (Ansell et 
al., 2011). This is due to skin injury activating the IFE and HF stem cells, which 
subsequently migrate to the epidermal wound and assist in regeneration (Carrasco 
et al., 2015, Lewis, 2013). 
The HF stem cell regions is humans is colloquially termed the bulge region 
(discussed previously), the structure of the HF in this region facilitates a dual 
function for the CD200+ stem cells found here. The ORS where the bulge is located 
is continuous with both the base of the hair follicle and the IFE, allowing the stem 
 60 
 
cells to migrate to either, regenerating the HF or to supply epidermal stem cells in 
response to wounding (shown in Fig 1.6b) (Cotsarelis, 2006). Generally these stem 
cells maintain a high proliferative potential but are usually quiescent and can remain 
dormant for extended periods (several months) only being activated when required 
for HF or wound regeneration (Lavker and Sun, 2000, Wong and Reiter, 2011). An 
absence of all hair follicles has been shown to have no effect on epidermal integrity 
or homeostasis; however it is detrimental to wound healing (Weyandt et al., 2009, 
Waters et al., 2007). 
A previous study indicated that transplantation of HF stem cells may serve a role in 
managing chronic wounds; mice which have undergone bulge cell transplantation 
can repopulate epidermis, sebaceous gland and epithelial layers of the HF itself 
(Oshima et al., 2001). However more recent studies have countered this, 
demonstrating that the recruitment of hair follicle stem cells to the wound was not 
required for adequate wound healing (Driskell et al., 2015).  
IFE and HF stem cells have previously been shown to maintain open chromatin 
states at genes unrelated to their lineage, suggesting they reserve the potential to 
transition to a close lineage if required (Bock et al., 2012). Moreover, genome wide 
methylation studies have demonstrated that many adult progenitor cells have 
distinct methylation patterns required to maintain their stem cell like properties, and 
a change of this methylation pattern is associated with lineage differentiation 
(Botchkarev et al., 2012). It has been shown that epigenetic regulator changes 
expression at the wound edge change drastically compared with normal healthy 
epidermis. Ezh2 and Eed, members of PRC2, are drastically down regulated in 
wounded mouse epidermis, while the histone demethylase Jmjd3 is upregulated, 
this results in fewer H3K27me3 histone modifications, specifically at the c-Myc and 
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Egfr genes, indicating that a loss of PCR2 mediated repressive histone 
modifications are required for wound healing (Shaw and Martin, 2009, De Santa et 
al., 2007).  
De novo hair follicle neo-genesis has also been observed in cases of wound 
healing. It was shown that the bulge derived stem cells in mice are not the 
progenitors of the new hair follicle placodes (Ito et al., 2007). It has also been shown 
that IFE stem cells are unipotent, only giving rise to the epidermis (Plikus et al., 
2015). However, this has only been tested in vitro and with small wounds, 
responses to large scale wounds, or wounds on larger mammals, have yet to be 
tested. 
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Figure 1.6 Epidermal wound healing
a) Phases of wound healing. b) Contribution of HF stem cells to epidermal healing, 
markers and key signalling pathways are noted. (Images adapted from Polimeni et 
al., 2006 and Brownell et al., 2011) 
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Research Aims 
 Determine expression of SWI/SNF chromatin remodelling complex specific 
subunits composition in human epidermis and hair follicle. 
It has previously been demonstrated that SWI/SNF complexes with a specific 
composition of subunit proteins is capable of regulating cell specific differentiation, 
with that in mind aim one is to determine if there is a specific SWI/SNF complex at 
work within human epidermis and hair follicles. Beginning with determining which 
ATPase subunit is most prevalent, as BRG1 and BRM are mutually exclusive, then 
to determine if BAF or PBAF complexes are present within the same systems, and if 
so then determining if there is a specific role for each variant. 
 Determine the role (if any) of SWI/SNF complexes in control of human hair 
growth. 
A previous study has linked BRG1, a central subunit of the SWI/SNF complex, with 
maintaining the hair follicle stem cell reservoir in mice, building on that aim two is to 
determine if SWI/SNF complexes play a role in regulating human hair follicle growth. 
This will be investigated by using a siRNA inhibitor to suppress key components of 
the SWI/SNF complex, and measuring the total growth after transfection, 
additionally any effect on the rate of anagen-catagen transition between groups will 
also be investigated. 
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 Identify the role of SWI/SNF chromatin remodelling complexes in epidermal 
keratinocyte migration during cutaneous wound healing. 
As previously discussed SWI/SNF complexes have a defined role in terminal 
differentiation of the epidermis, however, there a potential role for SWI/SNF 
complexes in cutaneous wound healing has not yet been investigated. As such, aim 
three is to determine if SWI/SNF complexes have a role in cellular migration, 
proliferation, apoptosis or other associated processes during cutaneous wound 
healing. The siRNA mediated suppression technique will also be used along with an 
ex-vivo wound healing model to determine any effect the complex has.
  
 
 
 
 
 
 
 
 
 
2. Materials and Methods 
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Table 2.1 Donor information 
 
Sample Type Age/Sex of the 
donor 
Location of 
sample 
Experimental 
usage 
Full thickness Skin 64 
Female 
Facelift Ex vivo 
wounding and IF 
staining 
Full thickness Skin 67 
Female 
Facelift Ex vivo 
wounding and IF 
staining 
Full thickness Skin 69 
Female 
Facelift Ex vivo 
wounding and IF 
staining 
Full thickness Skin 62 
Female 
Facelift Keratinocyte 
isolation and 
Scratch assay 
Full thickness Skin 57 
Female 
Facelift Keratinocyte 
isolation and 
Scratch assay 
Full thickness Skin 65 
Female 
Facelift Keratinocyte 
isolation and 
Scratch assay 
Full thickness Skin 63 
Female 
Facelift Keratinocyte 
isolation and 
Scratch assay 
Follicular Extraction 
Unit 
39 
Male 
Occipital scalp RNA isolation 
and Staining 
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Follicular Extraction 
Unit 
69 
Male 
Occipital scalp RNA isolation 
and Staining 
Follicular Extraction 
Unit 
48 
Male 
Occipital scalp RNA isolation 
and Staining 
Follicular Extraction 
Unit 
65 
Male 
Occipital scalp RNA isolation 
and Staining 
Follicular Extraction 
Unit 
45 
Male 
Occipital scalp RNA isolation 
and Staining 
Follicular Extraction 
Unit 
62 
Male 
Occipital scalp RNA isolation 
and Staining 
Follicular Extraction 
Unit 
54 
Male 
Occipital scalp SMARCA4 
siRNA 
transfection 
Follicular Extraction 
Unit 
35 
Male 
Occipital scalp SMARCA4 
siRNA 
transfection 
Follicular Extraction 
Unit 
68 
Male 
Occipital scalp SMARCA4 
siRNA 
transfection 
Follicular Extraction 
Unit 
52 
Male 
Occipital scalp SMARCA4 
siRNA 
transfection 
siRNA  
Follicular Extraction 
Unit 
57 
Male 
Occipital scalp SMARCC1 
/SMARCC2 
siRNA 
transfection 
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Follicular Extraction 
Unit 
65 
Male 
Occipital scalp SMARCC1 
/SMARCC2 
siRNA 
transfection 
Follicular Extraction 
Unit 
68 
Male 
Occipital scalp SMARCC1 
/SMARCC2 
siRNA 
transfection 
Follicular Extraction 
Unit 
46 
Male 
Occipital scalp SMARCC1 
/SMARCC2 
siRNA 
transfection 
Purchased 
keratinocytes 
Neonatal 
Male 
Foreskin Scratch assay  
Purchased 
keratinocytes 
Neonatal 
Male 
Foreskin Scratch assay  
Purchased 
keratinocytes 
29 
Female 
Breast Scratch assay 
and 
Transcriptomics 
Purchased 
keratinocytes 
29 
Female 
Breast Scratch assay 
and 
Transcriptomics 
Purchased 
keratinocytes 
29 
Female 
Breast Scratch assay 
and 
Transcriptomics 
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2.1 Human tissue procurement 
All human tissue samples were obtained either as full thickness skin from 
cosmetic/elective surgery procedures through our ethical tissue department at the 
University of Bradford, or the excess from follicular unit extraction (FUE) techniques 
used during hair transplant surgery, directly from the Farjo hair institute 
(Manchester). A full list of donors/samples can be found in table 2.1. 
2.1.1 Human tissue preparation 
Full thickness human skin tissue samples were either; used directly for Ex vivo 
wounding experiments (described in 2.3.2), or embedded in OCT (optimal cutting 
temperature compound) and snap frozen using liquid nitrogen, and stored at -80°C 
until required 
FUEs were manually dissected and trimmed of surrounding tissue, and cut at the 
isthmus/infundibulum boundary with a scalpel blade and either; placed into hair 
follicle culture media (Williams-E media (Gibco) with 2 mmol/L L-glutamine 
(Glutamax® ), hydrocortisone 10ng/ml, insulin 10 μg/ml, penicillin 100 U/ml, 
streptomycin 100 µg/ml (hereafter termed HF media)), for transfection experiments 
(described in 2.2), embedded in OCT and frozen at -80°C, or placed in TRI reagent 
(Zymo Research #R2050-1-200). 
2.2 siRNA mediated transfection of isolated hair follicles 
Isolated hair follicles were incubated overnight (at 37°C 5%Co2) in HF media to 
assess growth; those which showed evidence of continued growth, defined as new 
growth beyond the original cut at the isthmus/infundibulum boundary (Langan et al., 
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2015), were selected for transfection experiments, hair follicles which showed no 
growth were excluded. 
Transfection was carried out using Accell siRNA, targeting either SMARCA4 
(Dharmacon #E-010431-00-0005), SMARCC1 (Dharmacon #E-010813-00-0005), 
SMARCC2 (Dharmacon #E-010812-00-0005), or non-targeting control (Dharmacon 
#D-001910-10-05), as directed by the manufacturer’s directions. Briefly this involves 
diluting the siRNA in serum free Williams E media (Gibco # 12551032) 
supplemented with Hydrocortisone 10ng/ml (w/v) (Sigma-Aldrich #H6909), L-
glutamine 10µl/ml (v/v) (ThermoFisher #25030081) and insulin 1µl/ml (v/v) 
(hereafter referred to as HF2 media). Creating a 1µM final concentration, hair 
follicles were then grown in siRNA/HF media for 3 days, the media was then 
changed for HF media for a further 3 days (6 days total). Follicles where then either 
snap frozen in OCT using liquid nitrogen, and stored at 80°C or placed in TRI 
reagent until required.  
2.3 Partial thickness Ex Vivo wound healing model 
2.3.1 Twin scalpel laceration tool 
A modified scalpel tool was used to create a linear incision (rather than a punch 
biopsy which is generally used) as a model for the wound (Stojadinovic and Tomic-
Canic, 2013), this tool is simply two clean scalpel blades/handles attached securely 
together (as shown in figure 2.1). This tool creates a uniform dual line incision along 
the length of the tissue and provides a more reproducible partial thickness wounding 
model. 
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2.3.2 Partial thickness Ex vivo wounding model 
Full thickness non-hairy skin samples were obtained from female donors (60’s) 
(refer to table 2.1) who had undergone facelift surgery. The sample was then placed 
in a 50ml falcon tube containing 1x PBS and gently vortexed; this was repeated up 
to 3 times (to clear any remaining blood from the sample). The skin was then 
removed from the tube and placed, epidermis down, in a sterile P100 dish 
containing 5ml 1x PBS and the excess fat trimmed using forceps or scissors, once 
trimmed the skin was washed again (as previously described). The skin was then 
placed, dermis down, in a sterile P100 dish containing 5ml, then, using forceps to 
pin the skin in place, a dual straight line incision was cut into the skin (ensuring that 
the blades did not cut clean through the epidermis and dermis, but only the dermis) 
using the twin scalpel blade tool described in 2.3.1, this incision was then removed 
using scissors or forceps. The skin was then cut into appropriate sizes (~10mm2) 
and placed into 24mm transwell inserts, which were then placed into 6 well multiwall 
plates which contained 2ml of complete DMEM media (Dulbecco’s modified eagle 
media (DMEM) supplemented with sterile 10% FBS, 25nM HEPES, 100 unit/ml 
penicillin & 100ug/ml streptomycin, 2mM L-glutamine and 100mM sodium pyruvate 
(all supplied from Gibco), after inserting the transwell inserts to the multiwell plate 
and additional 1.2ml of DMEM was added to the transwell insert (siRNA transfection 
solutions (Described in 2.3.3) were added directly to the wound area at this point) 
and the lid placed on the plate. The wounds were then placed in an incubator 
(37°C/5%CO2), and media replaced every 2 days. 
Wounds were left for 1, 3, 5 or 7 days, at which point the samples were imaged 
using a GXCAM-9 camera and GX7 imaging software (GT Vision Ltd) on a Nikon 
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SMZ1000 steromicroscope, then embedded in OCT, snap frozen in liquid nitrogen 
and stored at -80°c until needed. 
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Figure 2.1: Making the twin blade tool 
 
Figure 2.1, a simple twin blade cutting tool created from two scalpel blades taped 
together to give a uniform dual laceration in the tissue  
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2.3.3 Transfection of partial thickness ex-vivo wounds using lipofectamineTM 
RNAiMAX 
Small interfering RNAs (siRNAs) were used for transient transfection, human 
SMARTpool: ON-TARGETplus siRNAs directed against SMARCA4 and a non-
targeting control were purchased (Dharmacon L-010431-00-0005 and D-001810-10-
05, respectively). 
Lipofectamine RNAiMAX/siRNA complexes were prepared as described in the 
manufacturer's protocol, with the exception that 50 pmol final concentration was 
used rather than the suggested 25 pmol (preliminary experiments determined that 
25 pmol was insufficient). Briefly, this protocol involved preparing the lipofectamine 
complex, the siRNA complex and then combining them. 250µl of final transfection 
solution was then added to each well and incubated for 48 hours (37°C/5%CO2), 
and media replaced every 2 days.  
Transfected partial thickness ex-vivo wounds were left for 3, 5 or 7 days at which 
point the samples were imaged using a GXCAM-9 camera and GX7 imaging 
software (GT Vision Ltd) on a Nikon SMZ1000 steromicroscope, then embedded in 
OCT, snap frozen in liquid nitrogen and stored at -80°c until needed. 
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2.4 Cell culture 
2.4.1 Sample preparation 
Primary human keratinocytes (PHEKs) were obtained from either full thickness skin 
donations, or purchased from PromoCell (C-12001 and C-12003), refer to table 2.1.  
2.4.1.1 Primary isolation of human keratinocytes 
The tissue was washed and trimmed as described in 2.3.2 (stopping before the 
lacerations were made). After trimming the tissue it was submerged in a falcon tube 
containing 5ml dispase solution (1U/ml) and incubated at 4°C overnight. After 
incubation the tissue and dispase solution were transferred to a sterile P100 dish 
and the epidermis separated from the dermis (this was done using forceps to hold 
the dermis and epidermis and peel them apart). Then the separated epidermis was 
placed into a falcon tube containing 5ml 1x Trypsin/EDTA (Gibco 25300054) (the 
separated dermis can be used for isolation of dermal fibroblasts or discarded) and 
incubated at 37°C for 30 mins, briefly mixing/vortexing every 5 minutes. The trypsin 
was then neutralised using trypsin neutralising solution (PromoCell #C-41100), the 
solution was then passed through a 70µm cell strainer into a fresh falcon tube and 
centrifuged at 180g for 5 mins to give a pellet, the pellet was then resuspended in 
10ml of complete keratinocyte growth medium 2 (KGM2 (PromoCell #C-20011) 
supplemented with Bovine Pituitary Extract 0.004 ml/ml, Epidermal Growth Factor 
(recombinant human) 0.125 ng/ml, Insulin (recombinant human) 5 μg/ml, 
Hydrocortisone 0.33 μg/ml, Epinephrine 0.39 μg/ml, Transferrin (recombinant 
human) 10 μg/ml, CaCl2 0.06 mM) and placed in a T75 flask (Corning 430641 and 
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placed in an incubator (37°C/5%CO2) ready for use. Media was replaced every 2 
days. 
2.4.1.2 Purchased primary human keratinocytes 
Purchased cells had undergone quality controls and were delivered in cryosolution 
ready for resuspension. Resuspension of cryopreserved samples was performed by 
adding 14ml of complete KGM2 media to a T75 flask, then warming the 
cryopreserved cells in the 37°C water bath (constantly swirling the tube of cells while 
warming), once fully thawed the cells were added to the 14ml KGM2 media and 
placed in an incubator (37°C/5% CO2), media was replaced every 2 days until cells 
were required. 
2.4.2 Splitting cells 
Once cultured cells reached <70% confluency they were split, this involved washing 
cells in 5ml sterile Dulbecco’s phosphate buffered saline (DPBS) (Gibco), then 
adding 3ml of 0.05% trypsin-EDTA solution (Gibco), detached cells were transferred 
to a 15ml falcon tube containing 3ml trypsin neutralising solution (Gibco). The 
combined mix was then centrifuged at 200 rcf for 5 mins, the supernatant was 
removed and the pellet resuspended in 10ml of complete KGM2 media cells were 
either split at a 1:4 ratio in a new T75 flask containing 12.5ml of complete KGM2 
media, or counted and seeded at 3.1 X 105 in 6 well plates, with 2ml of complete 
KGM2 media as required. Passaged cells were returned to the incubator at 
37°C/5% CO2 and media replaced every 2 days. 
PHEKs were seeded at 1.2 x 105 and cultured in 6 well plates, with 2ml of complete 
KGM2 media, for transfection, immuno-fluorescent analysis, qRT-PCR analysis and 
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scratch migration assay experiments. PHEK cells were grown to 60% confluency 
prior initiating any experiments. 
2.4.3 Transfection of cultured cells using lipofectamineTM RNAiMAX 
Small interfering RNAs (siRNAs) were used for transient transfection of primary 
keratinocyte cells (PHEKs), human SMARTpool: ON-TARGETplus siRNAs directed 
against SMARCA4 and a non-targeting control were purchased (Dharmacon L-
010431-00-0005 and D-001810-10-05, respectively). 
Lipofectamine RNAiMAX/siRNA complexes were prepared as described in the 
manufacturer's protocol, with the exception that 50 pmol final concentration was 
used rather than the suggested 25 pmol. Briefly, this protocol involved preparing the 
lipofectamine complex, the siRNA complex and then combining them. 250µl of final 
transfection solution was then added to each well and incubated for 48 hours, after 
incubation cells were used for either Immuno-fluorescent analysis, qRT-PCR 
analysis or scratch mediated wounding assay experiments. 
2.7.4 Fluorescent immunocytochemistry 
PHEKs were grown in 6 well plates containing sterile 16 X 16mm glass coverslips 
(Menzel Gläser) and 2ml complete KGM2, cells were seeded at 1.2x105/ml and 
grown to 60% confluency, then transfected using siRNA (as described in 2.4.3). 
Media was aspirated from the well and 2ml of 4% paraformaldehyde (v/v) added to 
each well for 10 mins, paraformaldehyde was then removed and wells were washed 
with 1xPBS 3 times for 2 mins each. 200µl of primary blocking solution (consisting of 
1% bovine serum albumin (BSA) (w/v), 0.01% Triton X-100 (v/v), 0.2% saponin 
(w/v), in 1x PBS) was added to each coverslip and left to incubate for 10 mins. 
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Primary antibody (detailed in table 2.1) were combined with primary blocking 
solution, 300µl of primary antibody mix was then added to each well, plates were 
then sealed with parafilm and incubated overnight at 4°C.  
After incubation primary antibody was removed and wells were washed 3 times with 
1xPBS for 5 mins each. Secondary antibodies prepared in 1%BSA/PBS and 200µl 
was then added to each well, plates were sealed with parafilm and incubated at 
37°C for 1 hour, after incubation wells were washed 3 times at 2 mins each with 
1xPBS. Vectashield antifade mounting medium with DAPI (Vector Laboratories H-
1200) was applied to clean slides; the coverslips were carefully removed from wells 
using forceps and placed face-down onto the vectashield slides, slides were allowed 
to dry before sealing with clear nail polish. Slides were stored at +4°C until viewed. 
Immuno-fluorescent analysis was carried out as described 2.7.3. 
2.4.5 Scratch mediated cell migration assay 
Preliminary experiments were carried our without the addition of Mitomycin C, all 
final experiments were with Mitomycin C treatment.  
6 well plates containing siRNA transfected cells, at >85% confluency, were further 
cultured for 2 hours in 2ml KGM2 10µg/ml mitomycin C. after mitomycin C treatment 
wells were washed 3 times using 2ml of sterile 1xPBS, after washing 2ml of 1x PBS 
was added to the wells. Using a sterilised ruler and 1000µl disposable pipette tip, a 
single vertical scratch was made in each well (Liang et al., 2007). Wells were 
washed again with 1xPBS and 2ml complete KGM2 media added, wells were then 
imaged at 1, 24 and 48 hours post scratching, total RNA was also isolated at 1, 24 
and 48 hours post scratching. 
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2.4.6 Scratch mediated cell migration closure rate 
Scratch assay wells were observed and imaged using a Nikon TS100 inverted 
microscope and Act-2u (Excel Technologies) imaging software and Nikon su41 
camera. Images taken at 10x (minimum 3 images per well). Analysis of images 
carried out using ImageJ software, an accurate scale was set and 30 measurements 
taken per image, statistical analysis carried out using Prism v.6, Mann-Whitney U 
Test, significance set as P=<0.05. 
2.5 RNA extraction and cDNA synthesis 
2.5.1 RNA isolation 
Total RNA was isolated from either isolated hair follicles (from FUEs or full thickness 
skin) or PHEK cell culture. Hair follicles were collected in 300µl of TRI reagent and 
mechanically homogenised using a mortar and pestle homogeniser (ThermoFisher 
#11522443). Cell culture isolates did not require homogenisation and were simply 
lysed in TRI reagent. 
RNA isolation was carried out using the ZymoBIOMICS RNA miniprep kit (Zymo 
Research #R2001, following the manufacturer’s protocol. In summary this involved 
adding an equal volume of absolute ethanol to the TRI reagent/tissue homogenate 
(ThermoFisher #10517694) and mixing thoroughly. This mix was then transferred to 
a Zymo-SpinTM column and centrifuged (all centrifugations were done at 13,000 x g 
and flow through discarded unless stated otherwise); 400µl RNA wash buffer was 
then added centrifuged for 1 min. The additional DNase digestion step was 
performed by adding the DNase mix (5µl DNase I and 75µl DNA digestion buffer) 
directly to the column membrane and incubated at RT for 15mins. After incubation 
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400µl of RNA prewash buffer was added and centrifuged, followed by 700µl RNA 
wash buffer and centrifuged for 2 mins, centrifuged again (to ensure all liquid has 
passed from the membrane tube to the collection tube), the collection tube was then 
discarded and a clean RNase free collection tube added to the column. To elute 
RNA 30µl of nuclease free water was added directly to the membrane and 
centrifuged, the membrane column was then discarded. 
RNA concentration and purity measured using an Implen P330 nonophotometer, 
any samples not falling within >1.8 to <2.0 280/260 and 230/260 wavelength 
absorption were rejected, RNA was then stored at -80°C until required. 
2.5.2 cDNA synthesis 
cDNA synthesis was performed using the qPCRBIO cDNA synthesis kit (PCR 
Biosystems #PB30.11-02) following the manufacturer’s protocol. Briefly, this used 
100ng of isolated total RNA (obtained as described in 2.5.1), which was added to 
4µl of 5x cDNA synthesis mix and 1µl of RTase and brought up to a total volume of 
20µl using PCR grade nuclease free water. cDNA was then synthesised using an 
Eppendorf® Mastercycler® Nexus thermal cycler (Eppendorf #EP6331000025) and 
Incubated at 42°C for 30 minutes, then 85°C for 10 minutes. Synthesised cDNA was 
then stored at -20°C until required. 
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2.6 RT-qPCR 
The qPCR mastermix was prepared as follows:-  
 
Reagent 
Volume 
 
qPCRBIO SyGreen mix Hi-ROX 
(PCR Biosystems #PB20.12-01)  
5µl 
 
Primer mix (forward and reverse) 5µM 
2µl 
 
cDNA 
0.5µl 
 
Nuclease free water 
2.5µl 
qPCR mastermixes were loaded into 96 well plates and centrifuged at 4000rpm for 5 
mins. 
qPCR carried out using a StepOnePlus real time PCR machine from applied 
Biosystems, and programmed using the StepOne software v2.1, ‘FAST’ functions, 
programme was set to 95°C for 2 minutes, then 40 cycles of 95°C for 10 seconds, 
30 seconds of the required annealing temp (table 2.1) and 72°C for 30 secs, finally 
after cycling a final elongation of 72°C for 5 mins. For all genes of interest RT-qPCR 
was performed in triplicate, melt curve analysis was carried out to ensure the validity 
of target amplification. Delta CT values were collated and relative expression levels 
of target genes generated with GAPDH used as housekeeping. cDNA synthesised 
from total human reference RNA (Clontech #636690) was used as a positive control, 
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total RNA was used as a negative control, finally all primers pairs were created to 
cross an intron/exon boundary on either the forward or reverse (table 2.2).   
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Table 2.2 List of primers used in qRT-PCR 
Gene  Sequence   
Annealing 
temp 
SMARCA4/BRG1 
 
FW: AACAACCTGAACGGCATCCT 
RV: CCAGTTGGACAGCGTTGAGA 
63 
SMARCA2/BRM 
 
FW: GAGCCCGAGTTTAGGAAGAGG 
RV: CAGTCAGTAGAGTAATGCTTGC 
63 
PBRM1/BAF180 
 
FW: AGCCATCACCTTTGCTGGAA 
RV: LCTTTGGGGTAGACTGTGGGG 
63 
ARID1a/BAF250a 
 
FW: CGGGGATGTATTCTCCTAGCC 
RV: TGGCCGCTTGTAATTCTGCT 
62 
ARID1b/BAF250b 
 
FW: GAAATATGAGCAGCATGACCCC 
RV: AAACTGCCTTGCCTGCTTTG 
62 
ARID2/BAF200 
 
FW: CACCACAGCAGAGGGTCG 
RV: TTCGCGAATCCGCCTAAAGT 
62 
SMARCC1/BAF155 
 
FW: AAATGAACAGGGATGGCGGA 
RV: GAGGTAGATGTTGGGTCTGGTC 
63 
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SMARCC2/BAF170 
 
FW: ATGACCGACCTGGATGAACAG 
RV: GGGAATGATGATGTGGTGGGT 
63 
SMARCB1/INI5/BAF47 
 
FW: GGACCAGTTTGAGTGGGACA 
RV: GGTTCTCGCTGAAGGCGTAG 
63 
K16 
 
FW: TATTCTTCCCGCGAGGTCTT 
RV: GTGGTAGAGGCAGCTCAGTT 
 
63 
K17 
 
FW: ATCCTGCTGGATGTGAAGACG 
RV: GGTGGTCACCGGTTCTTTCTT 
 
62 
GAPDH 
 
FW: TTGAGGTCAATGAAGGGGTC 
RV: GAAGGTGAAGGTGGGAGTC 
 
62 
 
RUNX1 
 
FW: CTGCCCATCGCTTTCAAGGT  
RV: GCCGAGTAGTTTTCATCATTGCC 
 
62 
 
CXCR2  
 
FW: CCTGTCTTACTTTTCCGAAGGAC 
 
RV: TTGCTGTATTGTTGCCCATGT 
 
62 
 
CXCL3  
 
FW: CGCCCAAACCGAAGTCATAG  
 
RV: GCTCCCCTTGTTCAGTATCTTTT 
 
62 
 84 
 
 
MMP7 
 
FW: GAGTGAGCTACAGTGGGAACA 
  
RV: CTATGACGCGGGAGTTTAACAT 
 
62 
 
SERPINA3 
 
FW: TGCCAGCGCACTCTTCATC  
 
RV: TGTCGTTCAGGTTATAGTCCCTC 
 
62 
 
KRT80 
 
FW: CCTCCCTAATTGGCAAGGTG  
 
RV: AGATGCCCGAGGTCGAAGAT 
 
62 
 
WNT4 
 
FW: GTACGCCATCTCTTCGGCAG  
 
RV:GCGATGTTGTCAGAGCATCCT 
 
62 
 
KLF4 
 
FW:CCCACATGAAGCGACTTCCC  
 
RV:CAGGTCCAGGAGATCGTTGAA 
 
62 
 
SNAI1  
 
FW:TCGGAAGCCTAACTACAGCGA  
 
RV:AGATGAGCATTGGCAGCGAG 
 
62 
 
CDK1 
 
FW:AAACTACAGGTCAAGTGGTAGCC  
 
RV:TCCTGCATAAGCACATCCTGA 
 
62 
All primers were designed by myself using primer BLAST (Ye et al., 2012) and 
purchased from Sigma-Aldrich 
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2.7 Fluorescent Immunohistochemistry 
2.6.1 Sample preparation 
Embedded skin and hair follicle samples were cut using the cryostat microme 
HM550 (Thermofisher) set to -33°C for hairy skin or -30°C for hair follicles, sections 
were cut at a thickness of 8µm and collected onto adhesive SuperFrost Plus slides 
(VWR international, Cat, No: 631-0447) and stored at -80o until needed. 
2.7.2 Immuno-fluorescence staining procedure 
Prepared slides were selected from the freezer and allowed to air dry for 10 min at 
room temperature (RT), once dry samples were then encircled with a PAP pen 
(Vector Labs H-4000). The tissue was fixed using 4% paraformaldehyde/PBS (v/v) 
for 10 mins at RT in a coplin jar. Slides were then washed 3 times for 5 mins each in 
1x PBS. 100µl of primary blocking solution (consisting of 1% bovine serum albumin 
(BSA) (w/v), 0.01% Triton X-100 (v/v), 0.2% saponin (w/v), in 1x PBS) was then 
added to each section and left to incubate for 1 hour. Primary antibodies were 
prepared using primary blocking solution (as detailed in table 2.3) and 100µl of 
primary antibody mix added to each section, slides were then incubated overnight at 
+4°C in a humidified chamber. 
After incubation slides were washed in 1xPBS 3 times for 5 mins. The secondary 
antibody was prepared using 1% BSA/PBS, and 100µl of the secondary antibody 
mix was then added to each section and incubated at 37°C for 1 hour, after 
incubation slides were washed again (3x 5 mins) in 1xPBS. Sections were mounted 
using Vectashield antifade mounting medium with DAPI (Vector Laboratories H-
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1200) and coverslips added before sealing using clear nail polish. Slides were then 
stored at +4°C until needed. 
To ensure the validity, a control experiment was carried out for each secondary 
antibody, where no primary antibody was added to sections. All primary antibodies 
were validated by knockout studies by the manufacturer. 
Table 2.2: Antibody table 
 
Primary Antibody 
Dilution  Origin 
 
Mouse Anti-BRG1 
1:50 Santa Cruz (sc-17796) 
 
Rabbit Anti-BRM 
1:400 Abcam (ab15587) 
 
Rabbit Anti-BAF155 
1:400 Santa Cruz (sc-10756) 
 
Rabbit Anti-Ini1 (BAF47) 
1:400 Santa Cruz (sc-13055) 
 
Rabbit Anti-Ki67 
1:100 Abcam (ab15580) 
 
Rabbit Anti active caspase  3 
1:100 Abcam (ab2302) 
 
Secondary Antibody 
Dilution Origin 
 
Donkey anti-rabbit Alexa-Fluor 555 
1:200 Life Technologies (A31572) 
 
Goat Anti-mouse Alexa-Fluor 555 
1:200 Life Technologies (A11001) 
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2.7.3 Fluorescence microscopy 
Immunofluorescence staining was observed and imaged using a Nikon Eclipse 50i, 
fluorescent microscope, and image analysis software (image pro express 9.1, Media 
Cybernetics), using an Qimaging EXI aqua camera.  
2.7.4 Pair wise comparison of signal intensity of fluorescence images using 
ImageJ 
A semi-quantitative technique allowing for a comparison of signal intensity between 
cells/regions of an image was utilised with various immunofluorescence stained 
slides (McCloy et al., 2014). This technique involves measuring the intensity of 
target signal from cells/regions and subtracting the background value to give a 
corrected total cell fluorescence (CTCF) value, using the following calculation:-   
CTCF = integrated intensity – (area of cell or region X mean fluorescence of 
background) 
2.7.5 Haematoxylin and Alkaline phosphatase staining 
Solutions were prepared immediately before carrying out alkaline phosphatase (AP) 
staining. 
Solution A: 30mM Tris base, 7mM TrisHCL, 100mM NaCl in 1x PBS 
Solution B: 4M sodium Natrite, 4mM new Fuchsin 
Solution C: 600mM of Naphthol dissolved in DiMethylformamide 
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AP staining was carried out as previously described (Lewis et al., 2014, Sharov et 
al., 2006). First prepared slides were selected from the freezer and left to air dry for 
10 mins at RT; slides were then fixed in acetone at -20°C for 10 mins. Slides were 
then washed for 3 mins in 1x PBS. While slides were being washed solution A and B 
were mixed in a Coplin jar, solution C was then added, generating the AP solution. 
Once washed slides were placed in the AP solution for 15 mins, then washed again 
in 1x PBS for 5 mins. Haematoxylin was then added to each slide for approximately 
60 seconds; the slides were then placed in an empty coplin jar and washed under 
cold running water for 5 mins. Slides were then sealed with mounting medium and 
sealed with clear nail polish. 
2.7.6 Brightfield microscopy 
Slides were visualised and imaged using a Nikon Eclispe 50i microscope and image 
analysis software (image pro express 9.1, Media Cybernetics) using a moticam 5+ 
camera 
2.7.7 Analysis of SWI/SNF subunit protein levels in ex vivo wounds 
Fluorescent images of 3, 5, and 7 days post wounding skin were stained for BRG1. 
The relative expression levels of BRG1 were obtained and compared between the 
wound associated cells and the distal epidermis using the semi-quantitative 
technique described in 2.7.4. Mann-Whitney U test was used to determine any 
possible significance as the data was non parametric. 
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2.7.8 Analysis of efficient ex vivo wound healing  
Brightfield images of the ex vivo wounds were processed and analysed using 
ImageJ software (NIH), the wound edges were measured for both length and area, 
from the start of the wound to the leading edge of the epithelial tongue. The mean 
length and area were generated from 3 donors, at 2 different time points (3, and 5 
days) and compared between control siRNA treated or SMARCA4 siRNA treated 
wound tissue. Students T-test was performed to identify any significance. 
2.7.9 Analysis of proliferation and apoptosis in ex vivo wounds 
Fluorescent images of day 3, 5 and 7 post wounding skin were stained for Ki67 (a 
proliferation marker) and analysed using ImageJ software, counting the total number 
of cells and the total number of Ki67 strongly positive cells. Three time points from 
each donor and treatment group (SMARCA4 or control) were analysed. Mean 
percentage of Ki67 positive cells were obtained and Students T-test used to 
compare any possible significance. 
The same was carried out for active caspase 3 (an apoptosis marker). 
2.7.10 Analysis of proliferation and apoptosis in Hair follicles 
Fluorescent images of cryosectioned hair follicles were stained for Ki-67 (a 
proliferation marker) and analysed using ImageJ software, counting the total number 
of cells in the outer root sheath or the matrix region and the total number of Ki-67 
strongly positive cells in the same regions. At least 12 follicles from each donor and 
treatment group (SMARCA4, SMARCC1/SMARCC2 or control) were analysed. 
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Mean percentage of Ki-67 positive cells were obtained and Students T-test used to 
compare any possible significance. 
The same was carried out for active caspase 3 (an apoptosis marker). 
2.8 Microarray data 
2.8.1. Sample preparation 
RNA samples were obtained from siRNA transfected primary human epidermal 
keratinocytes (as described in 2.4.3) and frozen at -80°C until needed. 
All reagents utilised were provide as part of the Agilent One-Color RNA spike-in kit 
(5188-5282) of the Agilent Hybridisation Kit (5188-5242)  
2.8.1. Colour spike in 
The one-colour spike mix stock was heated to 37°C, vortexed and briefly 
centrifuged, and diluted as per manufacturer’s directions. Next the labelling reaction 
was prepared as directed in Table 2.3; the mix was then heated to 65°C for 10 
mins, then immediately chilled on ice for 5 mins, and finally mixed with cDNA master 
mix (detailed in Table 2.4). the combined colour spike and cRNA master mix was 
then incubated at 40°C for 2 hours, then 65°C for 15 mins and then chilled on ice for 
5 mins; the chilled samples were then added to 60ul of transcription master mix 
(detailed in Table 2.5) and incubated at 40°C for 2 hours. Samples were stored at 
-80°C until needed or used immediately for cRNA purification. 
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2.8.2. cRNA purification 
cRNA was purified using the Qiagen RNeasy mini kit (Qiagen #74104). 
20µl of nuclease free water was added to each cRNA sample (bringing final volume 
to 100µl), 350µl of buffer RLT was then added and mixed by pipetting/vortexing. 
Once mixed 250µl of molecular biology grade 100% ethanol was added and mixed 
by pipetting, the whole volume (700µl) was then transferred to an RNeasy mini 
column and collection tube and centrifuged at 13,000 rpm for 30 secs. The flow 
through and collection tube was discarded and the mini column placed into a new 
collection tube. 500µl RPE buffer was then added and the samples spun again for 
30 secs at 13,000 rpm, the flow through was discarded and this step repeated. The 
samples were then spun for 1 min at 13,000 rpm (to ensure all liquid was removed), 
the collection tube was then discarded and the mini column transferred to a clean 
1.5ml collection tube with a lid. 25µl of nuclease free water was added (to elute the 
cRNA) and incubated for 1 min before being spun at 13,000 rpm for 30 secs. The 
mini column was discarded and the eluted cRNA kept in the dark. Quantification was 
then completed using a nanodrop 1000 spectrophotometer, a spike in efficiency 
formula (
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐶𝑦3
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑅𝑁𝐴
  X 1000 = pmol Cy3 per µg cRNA) was applied and any 
samples scoring less than 1 (the efficiency threshold) were excluded. Samples were 
stored at -80°C or used directly for hybridisation. 
2.8.3. Hybridisation 
Hybridisation mix was prepared as detailed in Table 2.6, and gently mixed, samples 
were then incubated for 30 mins at 60°C to fragment RNA, then immediately chilled 
on ice for 1 min. 25µl of 2x GEx Hybridization Buffer HI-RPM was added to stop the 
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fragmentation reaction and carefully mixed by pipetting (avoiding introducing 
bubbles), the samples were then centrifuged at 13,000 rpm for 1 min and placed on 
ice while the hybridisation chamber was prepared. 
A gasket slide was loaded into the Agilent sureHyb chamber base and aligned as 
directed by the manufacturer, and 40µl of hybridisation sample was added to each 
gasket section. The array was slowly placed over the gasket slide and the Agilent 
SureHyb chamber was sandwiched and sealed as directed by the manufacturer.  
The chamber was then placed in a rotisserie hybridisation oven at 65°C for 17 
hours. 
After hybridisation slides were washed with GE wash buffer (provided in the kit) for 1 
min at room temp, then washed again with GE wash buffer for 1 min at 37°C, and 
finally in acetonitrile (room temp) for 10 secs. 
2.8.4. Scanning and analysis  
Hybridised slides were scanned using an Agilent microarray scanner; features were 
extracted using the Agilent feature extraction software.  
Features were then analysed using GeneSpring GX software (Agilent), and analysis 
confirmed using Galaxy open source bioinformatics platform. 
Differential expression of genes was obtained and analysed using DAVID GO term 
enrichment analysis. 
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Table 2.3 Labelling reaction 
 
Component 
 
Volume (per reaction) 
 
Nuclease free water 
 
Make up to 8.3ul total 
volume 
 
Spike-mix 3rd dilution 
(made per 
manufacturer’s direction) 
 
2.0µl 
 
T7 promoter primer 
 
1.2µl 
 
RNA volume 
 
200ng total 
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Table 2.4 cDNA master mix 
 
Component 
 
Volume (Per reaction) 
 
5x First strand buffer 
 
4µl 
 
0.1M DTT 
 
2µl 
 
10mM dNTP mix 
 
1µl 
 
MMLV-RT 
 
1µl 
 
RNaseOUT 
 
0.5µl 
Final volume 8.5µl 
 
Must be added in order 
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Table 2.5 Transcription master mix 
 
component 
 
Volume (Per reaction) 
 
Nuclease free water 
 
15.3µl 
 
4x Transcription buffer 
 
20µl 
 
0.1M DTT 
 
6µl 
 
50% PEG 
 
6.4µl 
 
RNaseOUT 
 
0.5µl 
 
Inorganic 
pyrophosphatase 
 
0.6µl 
 
T7 RNA polymerase 
 
0.8µl 
 
Cyanine 3-CTP 
 
2.4µl 
 
Total volume 
 
60µl 
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Table 2.6 Hybridisation mix 
 
Component 
 
Volume (per reaction) 
 
Cyanine 3-labeled cRNA  
 
600ng 
 
Nuclease free water 
 
Make cRNA volume up 
to 19µl 
 
10x blocking agent 
 
5µl 
 
25x fragmentation buffer 
 
1µl 
 
Total volume 
 
25µl 
 
  
 
 
 
 
 
 
 
 
 
3. Results 
 
 97 
 
3.1 SWI/SNF complexes modulates the balance between cell 
proliferation and differentiation in the human hair follicle. 
3.1.1 Cell-type specific composition of SWI/SNF complexes in different human 
hair follicle compartments. 
SWI/SNF chromatin remodelling complexes contain either BRG1 or BRM as the 
core ATPase (Kadoch et al., 2016, Kadoch and Crabtree, 2015). To determine the 
potential roles of these ATPases in human hair follicle biology, first the expression 
level of the SWI/SNF core subunits were analysed on the mRNA and protein level in 
the whole hair follicles. 
RT-qPCR analysis of the total mRNA isolated from whole hair follicles indicated a 
much higher expression level of BRG1 in comparison to BRM (Fig 3.1a). 
Furthermore, immuno-fluorescent analysis showed that both BRG1 and BRM 
proteins are expressed in the hair follicle, although, with slightly different expression 
patterns (Fig 3.1b and c). High level of BRG1 expression was observed in the bulb 
region as well as the inner and outer root sheaths, but undetectable in the dermal 
papilla and connective tissue sheath, while BRM protein was present in the dermal 
papilla and connective tissue sheath.  
Next, The expression of additional SWI/SNF subunits: SMARCB1/BAF47, 
SMARCC1/BAF155, and SMARCC2/BAF170 were investigated. These subunits are 
required for complex stability, preventing protein degradation as well as providing 
molecular scaffolding for additional subunits to incorporate into the SWI/SNF 
complex (DelBove et al., 2011) . 
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SMARCB1/BAF47 has a lower mRNA expression level than SMARCC1/BAF155 
and SMARCC2/BAF170, as well as a vastly different protein expression pattern to 
SMARCC1.  Interestingly, BAF47 protein is expressed in the pre-cortex region of the 
hair bulb and not the matrix, as is seen with other subunits, including BAF155, which 
has a similar expression pattern to BRG1 (Figures 3.1b, 3.2c). 
Human SWI/SNF complexes have 2 common variants, BAF and PBAF, each 
containing unique subunits in addition to the common ones (Hodges et al., 2016, 
Yan et al., 2005). I further analysed the presence of these subunits to determine if 
one or both SWI/SNF complex types are present in the human hair follicle cells. 
Expression of both BAF and PBAF complex specific subunits were detected at the 
mRNA level (Fig 3.3). 
In summary these data indicate specific expression patterns for specific SWI/SNF 
subunits and the presence of both BAF and PBAF variants in human hair follicles, 
which could suggest different roles for specific SWI/SNF complexes within hair 
follicle cell sub-populations. As BRG1 was established as the abundant ATPase 
core subunit and knowing that both BAF and PBAF complexes are present within 
the hair follicle supressing BRG1 would effectively suppress both BAF and PBAF 
variants of SWI/SNF complex in human hair follicles. 
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Figure 3.1 Expression of the SWI/SNF ATPase subunits in the human hair follicle 
(a) RT-qPCR analysis of SMARCA4/BRG1 and SMARCA2/BRM expression using 
RNA isolated from the whole hair follicle normalised to GAPDH. >5 follicles per 
donor, 6 donors per gene, and 3 replicates per gene, Mean mRNA expression and ± 
standard deviation are shown, p=0.0002, Student's T-Test. Immunostaining of (b) 
BRG1 protein, and (c) BRM protein expression in human hair follicles 
counterstained with DAPI, representative of 6 male donors between the age of 39 
and 69, mean age 54. Images taken at 100x magnification and stitched, expanded 
images at 200x magnification, Scale bars = 100µm.  
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Figure 3.2 Expression of SWI/SNF core subunits in human hair follicles 
(a) RT-qPCR analysis of SMARCB1/BAF47, SMARCC1/BAF155 and 
SMARCC2/BAF170 expression using RNA isolated from the whole hair follicle 
normalised to GAPDH. >5 follicles per donor, 6 donors per gene, and 3 replicates 
per gene, Mean mRNA expression and standard deviation are shown, Student's T-
Test. Immunostaining of (b) BAF47 protein, and (c) BAF155 protein expression in 
human hair follicles, representative of 6 male donors between the age of 39 and 69, 
mean age 54. Images taken at 100x magnification and stitched, expanded images at 
200x magnification, Scale bars = 100µm.   
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Figure 3.3 Expression of the mRNA encoding BAF and PBAF specific subunits in 
human hair follicles 
RT-qPCR analysis of ARID1a/BAF250a, ARID1b/BAF250b, and PBRM/BAF180 and 
ARID2/BAF200 expression using RNA isolated from the whole hair follicle 
normalised to GAPDH. >5 follicles per donor, 6 donors per gene, and 3 replicates 
per gene, Mean mRNA expression and ± standard deviation are shown. 
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3.1.2 SWI/SNF complexes control the cell proliferation in the outer root sheath, 
but not in hair matrix and are not essential for the short term sustaining of the 
human hair growth.  
As this data revealed that BRG1, but not BRM is predominantly expressed in the 
human hair follicle epithelium (Fig. 3.1a) it was selected as a suppression target to 
reveal the role of the SWI/SNF complex in the control of cell proliferation, 
differentiation and hair growth in the human hair follicle. The Accell siRNA 
technology was selected as to facilitate the suppression of SMARCA4/BRG1, The 
initial penetration tests indicated that it would serve as to efficiently deliver siRNA to 
the deeper parts of the whole hair follicles (Fig 3.4a). 
Treatment of human hair follicles in an ex vivo culture with SMARCA4/BRG1 siRNA 
resulted in significant reduction of BRG1 protein within 3 days (Fig 3.4b-d). The 
amount of hair growth of the ex vivo culture after the siRNA mediated BRG1 
suppression. This data indicated no significant changes in the hair shaft growth or 
anagen-catagen transition between control and BRG1 knockdown follicles (Fig. 3.5), 
suggesting that BRG1 is not required for sustaining anagen or for promoting hair 
growth, at least in short term ex vivo hair follicle culture.  
To determine, if BRG1 suppression could potentially lead to the longer term 
changes in the human hair growth, the analysis of cellular proliferation using 
immuno-fluorescent staining of the hair follicles with Ki-67 antibodies after treatment 
with the control or SMARCA4 siRNA. Surprisingly This analysis revealed a 
significant increase in the outer root sheath cell proliferation, while no significant 
changes in hair matrix cell proliferation has been observed (Fig. 3.6).  
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To further validate that these findings reflect the functional significance of SWI/SNF 
complex in control of the outer root sheath cell proliferation, the same analyses were 
repeated after using the Accell siRNA mediated suppression of SMARCC1/BAF155 
and SMACC2/BAF170. Studies using mouse models have previously demonstrated 
that loss of BAF155 and BAF170 results in a loss of SWI/SNF functionality. My 
analyses shown that siRNA mediated depletion of BAF155 and BAF170 (Fig. 3.7) 
does not affect hair growth in short term hair follicle culture ex vivo, and leads to the 
significant increase in the outer root sheath, but not hair matrix cell proliferation (Fig 
3.8, 3.9). 
In summary, these data demonstrated that in the human hair follicle during the 
anagen phase of hair cycle SWI/SNF complex controls the cellular proliferation in 
the outer root sheath, but is not essential for the anagen sustaining and hair shaft 
growth, at least in the short term.  
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Figure 3.4 Effective siRNA mediated suppression of BRG1 in the human hair follicle 
culture ex vivo 
(a) 
Validation of the Accell siRNA technology using the Accell human control siRNA kit 
– red, Demonstrates an efficient penetration and delivery of siRNA into difficult to 
transfect tissues. b) Relative corrected fluorescence comparing BRG1 protein signal 
intensity between control and BRG1 knockdown follicles. >5 follicles per donor, 4 
donors per group (Control/Treated), and 20 measurements per follicle. Mean signal 
intensity and ± standard deviation are shown. Mann-Whitney U test. Immunostaining 
of of BRG1 protein expression in human hair follicles treated with (c) control siRNA 
or (d) SMARCA4 siRNA, representative of 4 male donors between the age of 35 and 
68, mean age 55. Images taken at 100x magnification and stitched, expanded 
images at 200x magnification, Scale bars = 100µm.    
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Figure 3.5 Suppression of BRG1 in human hair follicles has no effect on short term 
growth, or anagen-catagen transition 
 
(a) Average hair follicle growth over 96 hours post transfection with either control 
siRNA or SMARCA4 siRNA treated hair follicles. >12 follicles per donor, 4 donors 
per group (Control/Treated), Mean total growth and ± standard deviation are shown, 
Student's T-Test. b) number of follicles which transitioned into Catagen phase 
during the experiment. >12 follicles per donor, 4 donors per group (treated/control), 
Mean percentage of anagen-catagen transitions and standard deviation are shown, 
Student's T-Test, representative of 4 male donors between the age of 35 and 68, 
mean age 55  
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Figure 3.6 Suppression of BRG1 in human hair follicles increases proliferation in the 
ORS but not the matrix region 
(a) Percentage of Ki-67 positive cells (positive cells/total cells in region) in matrix 
region and the outer root sheath; comparing control siRNA and SMARCA4 siRNA 
treated hair follicles. >12 follicles per donor, 4 donors per group (Control/Treated), 
Mean Ki-67 positive percentage (%) and ± standard deviation are shown, Student's 
T-Test. Immunostaining of Ki-67 protein expression in human hair follicles treated 
with (b) control siRNA or (c) SMARCA4 siRNA, representative of 4 male donors 
between the age of 35 and 68, mean age 55. Images taken at 100x magnification 
and stitched, expanded images at 200x magnification, Scale bars = 100µm.   
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Figure 3.7 Effective siRNA mediated suppression of BAF155 and BAF170 in the 
human hair follicle culture ex vivo. 
 
(a) Relative corrected fluorescence comparing BAF155 protein signal in control 
siRNA treated and SMARCC1/SMARCC2 siRNA treated human hair follicles. >12 
follicles per donor, 4 donors per group (Control/Treated), and 20 measurements per 
follicle, Mean corrected fluorescence value and ± standard deviation is shown, 
Mann-Whitney U Test. Immunostaining of BAF155 protein expression in human hair 
follicles treated with (b) control siRNA or (c) SMARCC1/SMARCC2 siRNA (c), 
representative of 4 male donors between the age of 46 and 65, mean age 56. 
Images taken at 100x magnification and stitched, expanded images at 200x 
magnification, Scale bars = 100µm.  
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Figure 3.8 Suppression of BRG1 in human hair follicles has no effect on short term 
growth, or anagen Catagen transition 
 
(a) Average hair follicle growth over 96 hours post transfection with either control 
siRNA or SMARCC1/SMARCC2 siRNA treated hair follicles. >12 follicles per donor, 
4 donors per group (Control/Treated), Mean total growth and ± standard deviation 
are shown, Student's T-Test. b) number of follicles which transitioned into Catagen 
phase during the experiment. >12 follicles per donor, 4 donors per group 
(treated/control), Mean percentage of anagen-catagen transitions and standard 
deviation are shown, Student's T-Test, representative of 4 male donors between the 
age of 46 and 65, mean age 56. 
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Figure 3.9 Suppression of BAF155 and BAF170 in human hair follicles mimics the 
effects seen in BRG1 suppression 
(a) Percentage of Ki-67 positive cells (positive cells/total cells in region) in matrix 
region and the outer root sheath; comparing control siRNA and 
SMARCC1/SMARCC2 siRNA treated hair follicles. >12 follicles per donor, 4 donors 
per group (Control/Treated), Mean Ki-67 positive percentage (%) and ± standard 
deviation are shown, Student's T-Test. Immunostaining of Ki-67 protein expression 
in human hair follicles treated with (b) control siRNA or (c) SMARCC1/SMARCC2 
siRNA, representative of 4 male donors between the age of 46 and 65, mean age 
56. Images taken at 100x magnification and stitched, expanded images at 200x 
magnification, Scale bars = 100µm.   
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3.2 BRG1 controls the epithelial cell migration during cutaneous 
wound healing 
3.2.1 Both SWI/SNF ATPases BRG1 and BRM are expressed in the human 
epidermis 
Several studies have previously demonstrated that SMARCA4/BRG1 plays a crucial 
role in epidermal development by controlling late epidermal keratinocyte 
differentiation and barrier formation in both mice (Indra et al., 2005, Mardaryev et al., 
2014) and humans (Bao et al., 2013, Bao et al., 2015). However, the role of 
SMARCA4/BRG1 in human keratinocyte proliferation and migration during 
cutaneous wound healing remains unknown. To provide potential insight about the 
role of SWI/SNF complexes in human cutaneous wound healing the expression of 
SWI/SNF subunits in the epidermis was determined using immuno-fluorescence 
techniques combined with a semi-quantitative fluorescence intensity measuring 
technique, this technique allows for an active comparison of the target protein at 
specific sites between two groups, however it does not give a precise level of activity 
of the target protein, only a quantification of the fluorescent signal intensity. This 
analysis revealed the similar expression pattern of both BRG1 and BRM throughout 
the epidermis; however BRG1 appears more prominently than BRM, especially in 
the supra-basal epidermis (Fig. 3.10).  
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Figure 3.10 Both BRG1 and BRM are expressed in human epidermis. 
Immunostaining for SWI/SNF ATPase subunits (a) BRG1 and (b) BRM in human 
epidermis. Representative images of 3 female donors aged between 64 and 69. 
Images taken at 100x magnification, scale bar = 100µm. c) Relative corrected 
fluorescence comparing BRG1 and BRM protein signal in the basal and supra basal 
epidermis of a single donor. 3 donors, 20 measurements per region, Mean corrected 
fluorescence value and ± standard deviation is shown, Mann-Whitney U Test. 
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3.2.2 BRG1 expression is upregulated in the hyper-proliferative and migrating 
epithelia of the skin wounds. 
As the previous data highlighted an abundance of BRG1 protein in the epidermis, 
the next step was to investigate the expression of BRG1 in ex vivo wounded skin 
using immunostaining, followed by the semi-quantitative measurement of the 
fluorescent signals. This analysis revealed that at day 3 of wounding a significant 
upregulation of BRG1 expression in the hyper-proliferative and migrating wound 
epithelia in comparison to the distant unaffected epidermis (Fig. 3.11).  
3.2.3 BRG1 regulates wound closure rate, but does not affect epithelial cell 
proliferation and apoptosis in the ex vivo wounded full thickness skin.  
By incorporating an siRNA mediated knockdown of SMARCA4/BRG1 (as described 
previously) with the human ex vivo wound healing model, a significant knockdown of 
BRG1 protein was observed after the 48 hour siRNA treatment (Fig 3.12a,b).  
Further analysis of the wound indicated a delay in wound healing was occurring, 
while healing was still occurring, the rate of wound closure was delayed (Fig 3.12c). 
Haematoxylin staining of both control and BRG1 knockdown wounds at 3 and 5 
days post wounding revealed the average length of hyper-proliferative and migrating 
epithelia was significantly decreased, while the average thickness of the epidermis 
was increased (Fig 3.13).  
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In order to determine the specific mechanism underpinning this delay, markers for 
proliferation and apoptosis (Ki-67 and active caspase 3) were analysed using 
immunostaining. However, no difference was seen with either marker (fig 3.14 and 
3.15). These data indicate that BRG1 plays a role within wound healing by 
modulating migration pathways, but not proliferation or apoptosis pathways. 
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Figure 3.11 BRG1 protein expression is significantly upregulated in hyper-proliferative 
and migrating wound epithelia. 
Immunostaining of BRG1 in (a) human ex vivo wound edge and (b) distal unaffected 
epidermis. Dashed line denotes hyper-proliferating and migrating wound epithelia, 
scale bars = 100µl. c) Relative corrected fluorescence comparing BRG1 signal in 
the hyper-proliferative and migrating epithelia and distal unwounded epidermis of a 
single donor at 3 days post wounding. 3 donors, 20 measurements per region, Mean 
corrected fluorescence value and ± standard deviation is shown, Mann-Whitney U 
Test.  
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Figure 3.12 BRG1 suppression significantly delays the rate of wound healing in ex 
vivo wounds. 
Immunostaining of BRG1 in human ex vivo day 3 wounds treated with (a) control 
siRNA or (b) SMARCA4 siRNA. Dashed line denotes base of the wound edge, 
arrows highlight positive BRG1 cells, scale bars = 100µl. c) Relative corrected 
fluorescence comparing BRG1 signal in the hyper-proliferative and migrating 
epithelia between control and SMARCA4 siRNA treated wounds of a single donor at 
3 days post wounding. 3 donors, 20 measurements per region, Mean corrected 
fluorescence value and ± standard deviation is shown, Mann-Whitney U Test. d) 
Representative stereomicroscope images of partial thickness ex vivo wounds 
treated with control siRNA or SMARCA4 at 1 and 3 days post wounding. Black 
dashed line indicates initial wound, red dashed line denotes closing wound edge. 
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Figure 3.13 BRG1 suppression significantly reduces the length of wound edge during 
cutaneous wound healing 
 
Haematoxylin staining of human ex vivo wounds day 3 treated with either non-
targeting control siRNA or SMARCA4 siRNA. White dotted line indicates the hyper-
proliferative and migrating epithelia. Comparison of wound characteristics between 
non-targeting siRNA and SMARCA4 siRNA highlighting differences in total wound 
length and wound thickness at 3 days post wounding (b) or 5 days post wounding 
(c). 3 donors, 20 measurements per region, Mean length or thickness and ± 
standard deviation is shown, scale bar = 500µm, Student’s T-Test. 
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Figure 3.14 BRG1 suppression has no effect on proliferation in the hyper-proliferating 
and migrating epithelia. 
Immunostaining of Ki-67 protein in human epidermal wound tissue 3 days post 
wounding treated with either control siRNA (a), or SMARCA4 siRNA (b). Wounds 
created in tissue from the same donor. White dashed line indicates the wound edge. 
Green arrow indicates area of higher magnification, white arrowheads indicate 
positive cells. n=3 donors, scale bar = 200µm. c) Percentage of Ki-67 positive cells 
(positive cells/total cells in region) in wound edge, comparing control siRNA and 
SMARCA4 siRNA treated ex vivo wounds. 3 donors, 3 images per wound, Mean Ki-
67 positive percentage (%) and ± standard deviation are shown, Student's T-Test. 
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Figure 3.15 BRG1 suppression has no effect on apoptosis in the hyper-proliferating 
and migrating epithelia. 
 
Immunostaining of Active caspase 3 protein in human epidermal wound tissue 3 
days post wounding treated with either control siRNA (a), or SMARCA4 siRNA (b). 
Wounds created in tissue from the same donor. White dashed line indicates the 
wound edge. Green arrow indicates area of higher magnification, white arrowheads 
indicate positive cells. n=3 donors, scale bar = 200µm. c) Percentage of Active 
caspase 3 positive cells (positive cells/total cells in region) in wound edge, 
comparing control siRNA and SMARCA4 siRNA treated ex vivo wounds. 3 donors, 3 
images per wound, Mean Active caspase positive percentage (%) and ± standard 
deviation are shown, Student's T-Test. 
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The delay in wound healing demonstrated in Figure 3.12 -3.13 combined with the 
lack of changes to proliferation and apoptosis seen in Figure 3.14 & 3.15, indicates 
that wound associated migration is regulated by BRG1 while proliferation and 
apoptosis is not, resulting in a shorter, but thicker wound edge in SMARCA4 siRNA 
transfected wounds. 
3.2.4 BRG1 controls primary human epidermal keratinocyte migration, but 
does not affect their proliferation and apoptosis after scratch wounding ex 
vivo. 
Taken together, the data from Figures 3.12 - 3.15 indicates a clear role for 
SMARCA4/BRG1 and the SWI/SNF complex in regulating migration during wound 
healing. However, due to the inherent limitations with partial thickness ex vivo 
wound healing models, further investigation would be increasingly problematic, as 
such the investigation was moved to a cultured keratinocyte monolayer model, this 
would grant a greater reproducibility as well as a wider array of downstream 
applications which could help to elucidate the specific mechanisms by which 
SWI/SNF regulates wound associated migration. Before beginning any new 
investigations it was first determined if the previously observed effects of BRG1 
suppression were accurately recapitulated in the cell culture model. To do primary 
human epidermal keratinocytes (PHEKs) were transfected using the same siRNA 
and Lipofectamine delivery method utilised for the ex vivo wounds (described in 
2.3.3 and 2.4.3). As previously seen in ex vivo, an efficient suppression of BRG1 
was achievable, and validated mRNA level and with immunostaining for BRG1 
protein (Fig 3.16). A more efficient knockdown was seen with cell culture than ex 
vivo transfection, suggesting that any effects seen may be exaggerated in 
comparison to the ex vivo model we used previously. 
 120 
 
A scratch wound assay was used to uncover the specific mechanisms involved in 
BRG1 regulation of migration, this technique is a relatively quick and simple method 
to determine the wound response and migratory capabilities of cultured cell 
monolayers (Liang et al., 2007).  
Immunostaining for proliferation and apoptosis (using Ki-67 and active caspase 3, 
respectively) was also carried out, revealing no significant change in either 
parameter when comparing control and SMARCA4 siRNA transfected PHEKs (Fig 
3.17), while a total percentage of PHEKs were positive for active caspase 3 in 
comparison to the ex vivo model, it is likely that this is simply an artefact of using a 
cell culture model over an ex vivo model. 
As it has been shown that BRG1 suppression has no effect on proliferation or 
apoptosis, but only migration PHEKs were also treated with Mitomycin C, which 
alkylates DNA preventing replication, prior to scratching. 
PHEKs were transfected with either control or SMARCA4 siRNA for 48 hours, then 
Mitomycin C for 2 hours, and then the scratch wound was inflicted, images and RNA 
were collected at 1 hours, 24 hours, and 48 hours post scratching (scheme of 
experiments is highlighted in Fig 3.18). 
While no significant differences were observed at 24 hours, a significant delay in 
migration was observed at 48 hours (Fig 3.15), supporting the data seen in ex vivo 
wounds. 
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Figure 3.16 Effective suppression of BRG1 in PHEKs after siRNA mediated 
suppression 
 
a) RT-qPCR analysis of BRG1 expression using RNA isolated from PHEKs 
transfected with either; control siRNA or SMARCA4 siRNA for 48 hours, mean 
expression normalised to GAPDH and ± standard deviation. 9 donors, 3 wells per 
group (control/treated) 3 replicates per gene.  Student’s T-test. Immunostaining for 
BRG1 protein in PHEKs transfected with either control siRNA (b) or SMARCA4 
siRNA (c). 200x magnification, scale bar = 50µm. 
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Figure 3.17 BRG1 suppression has no effect on proliferation or apoptosis on cultured 
PHEK monolayers 
 
Immunostaining for Ki-67 protein in cultured PHEKs transfected with either; control 
siRNA (a) or SMARCA4 siRNA (b). Immunostaining for active caspase 3 protein in 
cultured PHEKs transfected with either; control siRNA (c) or SMARCA4 siRNA (d), 
white arrowheads indicate positive cells. Comparison of either; Ki-67 positive cells 
(e) or active caspase 3 cells in both control and SMARCA4 siRNA transfected 
PHEKs. 9 donors, 3 wells per group, 3 measurements per well. Scale bar=50µm. 
Mean positive cells ± standard deviation. Student’s T-Test.  
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Figure 3.18 BRG1 suppression significantly delays migration in scratch wound assay 
at 48 hours 
a) Scheme of experiment. b) Representative images of the keratinocyte migration 
after scratching in either control or SMARCA4 siRNA cells, at 1, 24 and 48 hours 
post scratching. White dashed line denotes original scratch width; red dashed line 
denotes the edge of migrating keratinocytes. Scale bar =200µm c) box-whisker plots 
measuring width of wound comparing control siRNA and SMARCA4 siRNA at 1, 24 
and 48 hours. 2nd, 3rd quartiles, median, maximum and minimum values shown. 7 
Donors, 3 wells per group, 20 measurements per well, Mann-Whitney U test. 
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3.3 BRG1 controls epidermal keratinocyte migration during 
cutaneous wound healing by regulating the expression of the 
genes involved in the key wound response pathways. 
To further define the molecular pathways controlled by BRG1 in the human 
epidermal keratinocytes during the wound healing microarray transcriptome profiling 
analysis was performed using RNA isolated from the cells transfected with control or 
SMARCA4 siRNA followed by scratch wounding (scheme of experiment shown in 
Fig 3.19a).  First, the differences in gene expression were determined between the 
control siRNA treated cells collected in 1 and 24 hours after scratch wounding, 
reflecting immediate and intermediate wound response, this provided a baseline of 
gene expression changes taking place in response to scratch wounding response. 
This analysis highlighted a series of gene expression changes due scratch 
wounding, in total 5493 significant (1.8 fold up or down) expression changes were 
seen, 2266 upregulated and 3227 downregulated. Go term enrichment returned 
several common terms linked with wound healing. Cell migration and response to 
wounding GO terms were enriched in upregulated gene expression changes, while 
cell-cell adhesion, regulation of cell cycle and epidermis development GO terms 
were enriched in downregulated gene expression changes (Fig 3.19 and 
Supplementary data 7.3). in addition to GO terms matching wound healing, several 
specific gene expression changes were seen which matches previously reported 
data (Klein et al., 2017, Sass et al., 2017) (Fig 3.19 and Supplementary data 7.3), 
indicating the technique effectively recapitulates wound healing. 
Once the baseline of wound healing response was established, the effect of BRG1 
suppression on gene expression in cultured keratinocytes was investigated, 
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comparing SMARCA4 siRNA treated cells collected in 1 hour after scratch 
wounding, with the control siRNA treated cells collected in 1 hour after scratch 
wounding.  
This analysis showed a significant gene expression change in 7418 genes in total, 
with 546 upregulated targets and 6872 downregulated, supporting the previous 
studies that state BRG1 acts as a transcription activator (Kadoch and Crabtree, 
2015). Interestingly several GO terms involving wound healing response, cell 
migration and cytoskeletal organisation were enriched in the downregulated gene 
expression changes, indicated that BRG1 is required for adequate wound healing 
responses in keratinocytes (Fig 3.20), in the immediate short term as the wound is 
inflicted. 
To further determine effects of BRG1 suppression on keratinocytes a comparison of 
the comparing SMARCA4 siRNA treated cells collected in 24 hour after scratch 
wounding, with the SAMRCA4 siRNA treated cells collected in 1 hour after scratch 
wounding.  
This analysis showed a significant gene expression change in 3147 genes, with a 
roughly equal distribution between up and down regulated genes (1394 genes and 
1753, respectively). Of the 1394 upregulated genes only 53 were upregulated in 
BRG1 suppressed keratinocytes at both 1 hour and 24 hours after scratching, while 
512 genes (of 1753) were downregulated in both 1 hour and 24 hours after 
scratching, demonstrating that these changes are a result of the loss of BRG1, and 
not a result of the scratch based wound (Fig 3.21). Enrichment of GO terms for the 
upregulated genes indicates that BRG1 is required to repress mast cell identity, 
while enrichment of GO terms in downregulated genes are involved in migration and 
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cytoskeletal organisation (Fig 3.21 and Supplementary data 7.1 and 7.2). 
Additionally when BRG1 is down regulated GO term enrichment also highlights 
embryo implantation and epidermal differentiation terms, which is constant with 
previous data on the effects of BRG1 knockdown (Mardaryev et al., 2014, Reyes et 
al., 1998, Bultman et al., 2000, Bao et al., 2013), validating the analysis. 
To determine the wound healing specific pathways which are affected by the loss of 
BRG1, the expression changes of genes upregulated in control siRNA cells 
collected at 24 hours after scratching, were compared with genes which were 
downregulated in SMARCA4 siRNA treated cells collected at 24 hours after 
scratching. A total of 2266 targets were upregulated in the control siRNA treated 
cells at 24 hour after scratching, while 2724 targets were downregulated in 
SMARCA4 siRNA treated cells at 24 hours after scratching, with 918 of those genes 
overlapping (fig 3.22). Demonstrating that approximately 40% of the genes required 
for wound healing are regulated (either directly or indirectly) by BRG1, or the 
SWI/SNF complex. Enrichment of GO terms for these shared genes highlighted 
several terms linked with wound healing pathways, for instance migration, wound 
healing, inflammation and epithelial to mesenchymal transition pathways (fig 3.22 
and supplementary data 7.1, 7.2 and 7.3), all of which support the significant 
delays observed in the scratch mediated wound assays previously observed.  
Several key wound healing genes were also significantly differentially expressed 
with the loss of BRG1; the loss of these targets was validated using qRT-PCR (fig 
3.23). The expression of multiple KRT genes were shown to be regulated by BRG1, 
to further determine if these played a role in later wound healing qRT-PCR analysis 
of KRT16, and KRT17 (stress keratins) was carried out comparing control siRNA 
treated PHEKs and SMARCA4 siRNA treated PHEKs collected in 48 hours after 
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scratching. Interestingly, a failure to induce KRT16/17 was seen in the BRG1 
knockdown group. The expression of KRT16/17 is highly similar between control 
and BRG1 knockdown groups in control group; however at 48 hours a significant 
induction of KRT16/17 was seen in the control group meanwhile the expression 
remained unchanged in the BRG1 knockdown group (Fig 3.24a, 3.25a). K16 and 
K17, were also investigated using ex vivo wound model, which validated the 
significant decrease in levels of K16/K17 in the BRG1 knockdown group compared 
with the control group (Fig 3.24, 3.25).  
Taken together these data indicate that BRG1 is vital to promote an adequate 
wound response, by modulating the migratory capacity of keratinocytes. 
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Figure 3.19 Scratch mediated wound healing using control siRNA treated 
keratinocytes shows strong similarity to normal wound healing/scratch wound assay 
GO enrichment terms 
a) Scheme of experiment. Selected wound healing GO terms of the upregulated 
gene expression changes (b) and downregulated gene expression changes (c), 
using DAVID bioinformatic resources. Bars represent the log10 p-values of each 
category. n= 3 female donors aged 29 and 32. 
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Figure 3.20 BRG1 suppression shows an immediate enrichment of wound healing GO 
terms in downregulated gene expression changes 
Selected wound healing GO terms of the upregulated gene expression changes (a) 
and downregulated gene expression changes (b), using DAVID bioinformatic 
resources. Bars represent the log10 p-values of each category. n= 3 female donors 
aged 29 and 32. 
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Figure 3.21 BRG1 regulates several key pathways required for normal wound 
associated migration 
a) Venn diagram indicating the total number of genes upregulated due to BRG1 
suppression at either; 1 hour or 24 hour after scratching, the overlap are genes 
upregulated in at both 1 and 24 hours after scratching. b) GO term enrichment of the 
59 shared genes identified in (a) using DAVID bioinformatic resources. The bars 
represent the log10 p-values of each category. c) Venn diagram indicating the total 
number of genes downregulated due to BRG1 suppression at either 1 hour or 24 
hour after scratching, the overlap are genes downregulated in at both 1 and 24 
hours after scratching. d) selected GO term enrichment of the 512 shared genes 
identified in (c) using DAVID bioinformatic resources. The bars represent the log10 
p-values of each category. n= 3 female donors aged 29 and 32.  
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Figure 3.22 BRG1 controls expression of up to 40% of the genes required for wound 
associated migration 
a) Venn diagram indicating the total number of genes upregulated in control siRNA 
PHEKs at 24 hours after scratching, compared with number of genes downregulated 
in SMARCA4 siRNA at 24 hours after scratching, the overlap are genes upregulated 
in at 24 hours after scratching in control cells, but downregulated at 24 hours after 
scratching in BRG1 suppressed cells. b) GO term enrichment of the 918 shared 
genes identified in (a) using DAVID bioinformatic resources. The bars represent the 
log10 p-values of each category. n= 3 female donors aged 29 and 32. c) key genes 
regulated by BRG1 during wound associated migration 
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Figure 3.23 BRG1 suppression delays migration by regulating specific wound healing 
associated genes 
a) Fold change, as seen in microarray, of several wound healing and migration 
associated genes control siRNA treated PHEKs at 24 hours after scratching and 
SMARCA4 siRNA treated PHEKs at 24 hours after scratching. b) RT-qPCR 
validation of selected genes. Fold change shown,  n= 3 female donors aged 29 and 
32, Student’s T-Test.  
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Figure 3.24 BRG1 regulates migration by inducing an upregulation of stress keratin 
K16 
 
a) RT-qPCR analysis of K16 expression at 24 and 48 hours post scratching using 
RNA isolated from PHEKs transfected with either; control siRNA or SMARCA4 
siRNA, mean expression normalised to GAPDH and ± standard deviation. 3 donors, 
3 wells per group (control/treated), 3 replicates per gene, Student’s T-test. 
Immunostaining of K16 protein in human epidermal wound tissue 3 days post 
wounding treated with either control siRNA (b), or SMARCA4 siRNA (c). Wounds 
created in tissue from the same donor, scale bar = 100µm. d) Relative fluorescence 
comparing K16 protein signal intensity between control and BRG1 knockdown 
wounds. n=3 female donors per group (Control/Treated), and 20 measurements per 
wound. Mean signal intensity and ± standard deviation are shown. Mann-Whitney U 
test.  
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Figure 3.25 BRG1 regulates migration by inducing an upregulation of stress keratin 
K16 
 
a) RT-qPCR analysis of K16 expression at 24 and 48 hours post scratching using 
RNA isolated from PHEKs transfected with either; control siRNA or SMARCA4 
siRNA, mean expression normalised to GAPDH and ± standard deviation. 3 donors, 
3 wells per group (control/treated), 3 replicates per gene, Student’s T-test. 
Immunostaining of K16 protein in human epidermal wound tissue 3 days post 
wounding treated with either control siRNA (b), or SMARCA4 siRNA (c). Wounds 
created in tissue from the same donor, scale bar = 100µm. d) Relative fluorescence 
comparing K16 protein signal intensity between control and BRG1 knockdown 
wounds. n=3 female donors per group (Control/Treated), and 20 measurements per 
wound. Mean signal intensity and ± standard deviation are shown. Mann-Whitney U 
test. 
  
 
 
 
 
 
 
 
 
 
 
4. Discussion 
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4.1 Diverse SWI/SNF chromatin remodelling complexes are 
present in the human hair follicle  
To explore the potential role of the SWI/SNF chromatin remodelling complexes in 
the control of human hair growth the expression of genes encoding the SWI/SNF 
complex subunit in the whole isolated hair follicles were analysed using RT-qPCR 
and Immuno-fluorescent technology. 
These findings indicated that SMARCA4 mRNA is expressed at a much higher level 
than SMARCA2 mRNA in the majority of the whole hair follicle cells. Immuno-
fluorescent analysis also indicated slightly differing expression patterns for BRG1 
and BRM in the hair follicle; with both BRG1 and BRM being found in matrix and 
pre-cortex of the hair follicle bulb, and the inner and outer root sheaths of the of the 
hair follicle, with almost no BRG1 expression detected in the dermal papilla and 
connective tissue sheath. Meanwhile, BRM expression was found all cells of the hair 
follicle, including the dermal papilla and connective tissue sheath. 
Previous studies have demonstrated that SWI/SNF complexes with different subunit 
composition perform different functions, or driving differentiation, depending on the 
cell type and the differentiation state in mice (Kadoch et al., 2016, Kadoch and 
Crabtree, 2015). The differences observed could suggest that BRG1 containing 
SWI/SNF complexes are required mostly for the cell proliferation and differentiation 
of keratinocyte lineages; while BRM containing complexes might be required for 
maintaining cellular identity within mesenchymal lineages. 
To further uncover the diverse SWI/SNF complex subunit compositions in the 
human hair follicle, the expression of the core subunits SMARCC2, SMARCC1 and 
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SMARCB1 in the whole hair follicles was also investigated. These subunits are 
reported to be present in all the SWI/SNF complexes in postnatal organisms 
(Euskirchen et al., 2012). Interestingly, these data showed that SMARCC2 and 
SMARCB1 were expressed at comparable levels in whole hair follicles, while 
SMARCC1 mRNA was much more abundant. BAF155/BAF170 have been shown to 
form both homodimers and heterodimers, it is known that in mouse embryonic stem 
cells Baf155 is forms a homodimer and Baf170 is not expressed (Ho et al., 2009). 
This data suggests BAF155 might form homodimers in several human hair follicle 
cell sub-populations, potentially to maintain HF stem cells. However as individual 
cell populations were not investigated and so this has yet to be validated. 
It has also been shown that BAF155 specifically is required to bind to BAF47, via the 
SWIRM and RPT1 domain interaction of BAF155 and BAF47 respectively (Yan et 
al., 2017). However, the immuno-fluorescent analysis indicates BAF47 and BAF155 
are expressed in different cell sub-populations (shown in Fig 3.2), This contradicts 
the previously reported findings which stated that both BAF155 and BAF47 are 
required to provide full functionality to the SWI/SNF complexes (Phelan et al., 1999, 
Yan et al., 2017, Nakayama et al., 2017) in almost all tested tissues as well as 
several human cancers, it may also indicate that BAF47 has (as yet unknown) 
functionality beyond a SWI/SNF complex subunit in some human cell populations. 
The potential role for SWI/SNF complexes in regulating/maintaining hair follicle 
cycle, as mouse models have demonstrated a role for Brg1 during telogen to angen 
shift, BRG1 in humans could maintain anagen, so a loss of BRG1 could push hair 
follicles into catagen phase earlier than normal, however this was not the case as no 
significant change was seen between control and BRG1 knockdown follicles. There 
is a possibility of masking occurring during these experiments, as insulin is a 
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prominent growth factor. To counter this, a second experiment could have been 
carried out without insulin to determine if insulin was masking any potential role of 
BRG1 in maintaining anagen phase, or alternatively a known catagen inducer (INFγ 
for instance) could be used to force catagen and investigate any possible 
differences between control and BRG1 knockdown follicles. Unfortunately due to 
time constraints this was not pursued. 
Two families of the SWI/SNF complexes are present in mammals, termed BAF and 
PBAF (Kadoch and Crabtree, 2015, Kadoch et al., 2016). The presence of both BAF 
and PBAF complex specific subunits were seen in whole human hair follicles 
(ARID1a, ARID1b and ARID2, PBRM, respectively (Hodges et al., 2016)). Previous 
studies have indicated that the two complexes have different biological functions, as 
the complexes are evolutionarily conserved and their ancestral homologs have been 
shown to play different roles in both yeast and drosophila (Hodges et al., 2016, 
Dechassa et al., 2008, Molnar et al., 2006, Rendina et al., 2010). However, in 
mammals there are fewer specific examples of specific BAF or PBAF functions, as 
the BAF and PBAF complexes are assembled combinatorially, and they are likely 
assembled/disassembled transiently as need arises (Hodges et al., 2016, Wu et al., 
2009). Interestingly, there is some evidence indicating that PBAF complexes are 
required for maintaining genetic integrity during mitosis (Bajpai et al., 2010). Most 
other evidence of different roles for the specific BAF or PBAF complexes is found in 
cancer studies. Mutations in the SWI/SNF complex subunits are commonly found in 
cancers, with up to 20% of all cancers containing such mutations, and many of the 
subunits being tumour suppressors (Hodges et al., 2016, Arnaud et al., 2018, 
McBride et al., 2018). 
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While little evidence of different roles for the BAF and PBAF complexes has been 
confirmed, there is evidence of different roles of the SWI/SNF complex based on the 
composition of subunits. The diversity in the SWI/SNF complex composition 
observed in human hair follicles might also reflect that the composition changes are 
required during specific cell state transitions. Such a requirement has been 
demonstrated in the process of murine neuronal progenitor differentiation; where 
Actl6a/Baf53a and Phf10/Baf45a SWI/SNF subunits (found in the neuronal 
progenitor cells) being lost and their expression swapped with Actl6b/Baf53b, 
Dpf1/Baf45b and Dpf3/Baf45c subunits in the differentiated neurons (Lessard et al., 
2007). It was later demonstrated that microRNAs miR-9/9* and miR-124 facilitate 
this conversion by suppressing Baf53a expression during neuronal differentiation 
(Yoo et al., 2009). However, currently no similar mechanism has been described in 
regulation of human hair follicle cell sub-populations. 
4.2 SWI/SNF complexes play a role in maintaining cell 
proliferation balance in the outer root sheath of the human hair 
follicles 
To identify the potential role of the SWI/SNF complexes in the human hair follicle 
biology, BRG1, or BAF155 and BAF170 gene expression in whole hair follicles was 
suppressed using Accell siRNA technology. While an efficient suppression of either 
BRG1 or BAF155 and BAF170 was achieved no change in growth or anagen-
catagen transition was observed within the short term (6 days total culture time) in 
the ex vivo follicle culture (Fig 3.5, Fig 3.8). As previous experiments showed a 
higher expression level of these subunits in the matrix/pre-cortex of hair follicle 
bulbs, it was hypothesised that a loss of SWI/SNF would affect the proliferation 
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and/or differentiation of cells in these hair follicle compartments. However, analysis 
revealed no change occurred in the matrix/pre-cortex cell proliferation. However, 
unexpectedly, a significant increase in cell proliferation was seen in the outer root 
sheath, in many cases (approximately 60%) this was also accompanied by the 
swelling of the highly proliferative cell population (visible in Fig 3.6c, 3.7c, 3.9c). 
Currently, there are two possibilities that are most likely explaining these 
observations. First, the SWI/SNF complex might be required to restrict the epithelial 
stem cell proliferation in the outer root sheath during anagen. Interestingly, in mice 
Brg1 is required for the hair follicle stem cell activation and proliferation during 
anagen induction, and Brg1 deficiency leads to the inhibition of the anagen 
progression and stem cell pool depletion (Xiong et al., 2013). These observations, in 
comparison to the previously reported findings in mice, could reflect the distinct roles 
for Brg1 in control of stem cell activation and proliferation during telogen-anagen 
transition and control of the balance in proliferation in the outer root sheath during 
anagen. The second possibility is that SWI/SNF maintains the cell type specific 
expression programme of outer root sheath keratinocytes, and when BRG1 is lost 
the expression programme is changed leading to the changes in cell identity and 
resulting in the increased proliferation of the altered cells. The second hypothesis is 
also somewhat supported by the GO term enrichment analysis of the BRG1 
suppressed PHEKs (Figs 3.21, 3.22 and supplementary data), where the 
enrichment of several GO terms associated with keratinocyte differentiation, as well 
as other cell lineage identity are affected. Moreover, several keratins are 
downregulated when BRG1 is suppressed, namely KRT15 and KRT19 which are 
hair follicle specific keratins (Fig 3.23). There are multiple previous reports 
demonstrating the role of SWI/SNF in maintaining or orchestrating differentiation of 
multiple cell lineages (Fessing et al., 2011, Toto et al., 2016, Lessard et al., 2007). 
Taken together it is likely the latter of the two options is correct, However, further 
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studies using laser capture microdissection techniques to isolate the cells and 
determine any lineage specific changes in gene expression programmes using RT-
qPCR and or microarray transcriptome profiling technologies will be required. 
Throughout this investigation a number of insurmountable differences are 
encountered when comparing these data to previous studies involving mice. As 
mentioned there has been much more work carried out using mice, due to the ability 
to investigate developmentally, as well as a well understood hair cycling system, not 
to mention the ability to generate transgenic species to fully ablate expression of 
genes. All of these differences give multiple areas of investigation which cannot be 
mimicked using human studies. As previously mentioned in mouse models Brg1 has 
been linked to maintaining the stem cell reservoir of the bulge region, however this 
is only during telogen to anagen transition, with current technology this cannot be 
examined using a human model, roughly 5% of human hair follicles are in telogen 
phase, there is no way to accurately identify and extract them in order to perform 
hair cycle transition experiments. Additionally the hair cycle ‘wave’ that occurs in 
mice allows for precisely timed experiments which can be maintaining in vivo 
allowing for a long term investigation to take place, using human models hair 
follicles must be cultured ex vivo giving a finite time frame which can be observed, 
this method also removes the hair follicle from its micro-environment and results in a 
great amount of stress inflicted upon the follicle, before an investigation can even 
take place, potentially masking results with stress responses or (as previously 
mentioned) masking effects of the growth media which provides an abundance of 
growth factors and hormones. As such a true comparison of human and mouse hair 
follicle models cannot be carried out without accepting the limitations in place, 
retreating to the old adage “all models are wrong, but some models are useful”, a 
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direct comparison usually cannot be made, but should be used to guide further 
investigation.  
In summary, a diverse expression pattern of the SWI/SNF complex subunit 
encoding genes in human hair follicles suggests an important function of the 
SWI/SNF complex in control of the hair follicle activity. The suppression of BRG1, 
and co-suppression of BAF155 and BAF170 expression in ex vivo culture hair 
follicles using specific siRNA highlighted a distinct role for SWI/SNF complexes in 
the outer root sheath cells of hair follicles, however a specific molecular mechanism 
has to be identified in the future studies. 
4.3 The SWI/SNF complex modulates epidermal keratinocyte 
migration during cutaneous wound healing 
Previous studies have demonstrated that the BRG1 is required for normal epidermal 
development in both mice (Indra et al., 2005, Mardaryev et al., 2014) and humans 
(Bao et al., 2013); however its specific role in epidermal wound healing was 
previously unexplored. Using Immuno-fluorescence the expression of both BRG1 
and BRM ATPases was determined in human epidermis. Both BRG1 and BRM is 
expressed throughout the epidermis. However BRG1 was more abundant 
throughout the epidermis, especially in the supra-basal layer, which would support 
previous studies highlighting the role of BRG1 in terminal epidermal differentiation 
(Bao et al., 2013). 
Epidermal progenitor cell differentiation drives the epidermal self-renewal throughout 
the whole life of the organism, and BRG1 containing SWI/SNF complexes have 
been shown to be essential for this process (Bao et al., 2013, Indra et al., 2005, 
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Mardaryev et al., 2014). Moreover, these cells could also proliferate and migrate to 
the site of the skin injury for the wound re-epithelialisation. It has been shown that 
BRG1 is more abundant in the hyper-proliferative and migrating epithelia (HPE) of 
the wounds (Fig 3.11), suggesting that BRG1 is involved in the control of the wound 
re-epithelisation process. Building on this it was demonstrated that the suppression 
of the BRG1 expression leads to the significant delay in wound healing without 
effect on the cell proliferation or apoptosis at the wound edge (Fig 3.12-3.15). While 
previous studies have demonstrated that Brg1 is required for hair follicle stem cell 
proliferation as we as facilitating their contribution to the cutaneous wound healing in 
mice (Xiong et al., 2013). No studies have investigated the role of BRG1 in 
epidermal keratinocytes activation during cutaneous wound re-epithelialisation has 
not been reported prior to this investigation. 
To further investigate the role of BRG1 in wound healing migration a cell culture 
based scratch mediated wound healing assay using primary human epidermal 
keratinocytes (PHEKs) was utilised (Liang et al., 2007). Once again the suppression 
of BRG1 in these cells had no effect on proliferation or apoptosis (Fig 3.17) but a 
significant delay in migration was observed. As proliferation and apoptosis were 
unchanged by BRG1 suppression, BRG1 must regulate keratinocyte migration, 
resulting in a delay to wound closure when BRG1 is suppressed.  
Microarray transcriptome profiling and the GO term enrichment analysis of BRG1 
suppressed keratinocytes highlighted multiple terms linked with cell migration (Fig 
3.22c and supplementary data), such as cell migration, and cytoskeleton 
organisation, indicating that BRG1 regulates transcriptional wound response 
controlling cell migration. Additionally, GO term enrichment linked terms were 
associated with angiogenesis, epidermis development, and embryo implantation; all 
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of which have previously been linked to BRG1 functions (Lan et al., 2017, Bultman 
et al., 2000, Mardaryev et al., 2014).  
Further analysis of the microarray data indicates that BRG1 is a negative regulator 
of mast cell identity, as when BRG1 was suppressed many of the up-regulated 
genes were enriched for GO terms linked with mast cell chemotaxis and 
degranulation (Fig 3.19b, 3.20b and supplementary data). This has previously 
been alluded to in mouse T-cells (Wurster and Pazin, 2008), but no direct evidence 
was given. However, mast cell lineage has been shown to be regulated by a specific 
microphthalmia-associated transcription factor (MITF) isoform (Shahlaee et al., 
2007), and BRG1 has been shown in several studies to interact directly with various 
MITF isoforms (Ondrusova et al., 2013, Saladi et al., 2013, Mehta et al., 2015, 
Laurette et al., 2015), suggesting that this is the likely case with mast cells. 
However, this was not the focus of this work, so there has been no validation of this 
interaction. 
GO term enrichment of control siRNA treated PHEK scratch mediated wound 
samples shows significant enrichment of multiple terms involved in wound response 
(Fig 3.19b,c and supplementary data), including cell migration, cell-cell adhesion, 
cytoskeleton organisation, response to wounding, and several known wound 
response pathways (ERK, WNT, and NF κB). Several key wound healing 
transcription factors (including ZEB1, SNAI1, and GRHL3) were up-regulated as 
expected (Medici et al., 2008, Lamouille et al., 2014, Klein et al., 2017), indicating an 
accurate recapitulation of the wound healing process. 
After determining that the control group was an accurate facsimile for normal wound 
healing, the investigation of the BRG1 specific changes could take place. By 
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comparing the differences in expression seen in BRG1 suppressed PHEKs and 
control siRNA treated PHEKs at 24 hours post scratching, the significant gene 
changes would be due to the loss of BRG1. Focusing on the genes which are up-
regulated in control cells (which are similar to those seen in other wound healing 
studies) but down-regulated in BRG1 suppressed cells, a selection of genes 
involved in migration, which are also regulated by BRG1, would be highlighted. A 
total of 2266 genes were up-regulated in control wound response at 24 hours post 
scratch, while 2724 genes were downregulated in BRG1 suppressed scratch 
mediated wound cells collected at 24 hours after scratching, of these genes 918 
were overlapped, indicating that BRG1 is responsible for regulating approximately 
40% of the genes involved in keratinocyte migration (Fig 3.22a). Several key genes 
were in this list, including SNAI1, WNT4, KLF4 and SOX2; however ZEB1 and 
GRHL3 (prominent genes involved in epithelial-mesenchymal transition) expression 
were not affected by the loss of BRG1. 
To fully determine the changes occurring due to the loss of BRG1 chromatin 
immuno-precipitation and sequencing or assay for transposase-accessible 
chromatin using sequencing (ChIP-seq or ATAC-seq, respectively) would be 
needed, this would determine direct vs indirect targets as well as the binding sites of 
transcription factors or histone marks and the ‘chromatin landscape’, which would 
fully elucidate the changes occurring due to the suppression of BRG1 during 
keratinocyte migration.  
These findings suggest that BRG1 is required for migration, and epidermal-
mesenchymal transition (EMT), although not via ZEB1 or GRHL3 pathways. This 
data indicates that BRG1 is required for expression of SNAI1 (also termed SNAIL), 
which inhibits E-cadherin expression (Batlle et al., 2000, Cano et al., 2000), a 
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hallmark of EMT. As SNAI1 is an inhibitor of E-cadherin (CDH1) there should have 
been an increase in E-cadherin in BRG1 suppressed samples in 24 hours after 
scratching. However this was not the case, this is likely due to additional genes 
which regulate E-cadherin suppression, such as ZEB1 and ZEB2 (Andersen et al., 
2005), which were expressed at a higher level in BRG1 suppressed samples in 24 
hours after scratching (Fig 3.23a). 
Other key genes/pathways highlighted from the microarray analysis are in the WNT 
pathway. β-catenin independent Wnts, Wnt4, Wnt5a and Wnt11, have been seen to 
support wound healing in mouse models (Fathke et al., 2006). A more recent paper 
has highlighted a role of human WNT4 in increasing wound healing rate in second 
degree burns in rats (Zhang et al., 2015), this study utilised human umbilical cord 
mesenchymal stem cell derived exosomes (hucMSC-ex), which contain high levels 
of WNT4. This study showed that injection of the hucMSC-ex into the wound site 
increased the wound healing rate. Consistent with this observation, this investigation  
showed an increase in WNT4 in control siRNA treated cells at 24 hours after 
scratching, but a decrease in WNT4 in BRG1 suppressed cells at 24 hours after 
scratching, suggesting that WNT4 does play a role in keratinocyte migration (Fig 
3.23). 
Additionally, several enriched GO terms indicate BRG1 regulates cytoskeletal 
formation/organisation, normal epidermal wound healing response relies on a 
switching of cytokeratin (KRT) genes to direct the formation of the cytoskeleton for 
mobility, most notable of these is the activation of KRT6, KRT16 and KRT17 
(Wawersik et al., 2001, Mazzalupo et al., 2003, Wong and Coulombe, 2003). These 
keratins are required for normal wound induced cell migration, where they act 
through reducing desmosome stability and inter-cellular contacts in keratinocytes  
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controlled by the protein kinase C alpha (PKCα) localization near the cellular 
membrane (Loschke et al., 2016). In control siRNA treated cells at 48 hours after 
scratching KRT16 and KRT17 showed a significant increase in expression, however 
in BRG1 suppressed cells in 48 hours after scratching the expression of KRT16 and 
KRT17 showed no induction of expression (Fig 3.24a, 3.25a). The gene encoding 
PKCα (PRKCA) is also down regulated in BRG1 suppressed cells, there is also a 
significant decrease in the levels of K16/K17 protein in BRG1 knockdown day 3 
wounds, further supporting the role of BRG1 in regulating a number of KRTs, and 
not only those required in terminal epidermal differentiation as has been previously 
reported (Indra et al., 2005, Mardaryev et al., 2014, Bao et al., 2013).  
Taken together, these data indicate a specific role for BRG1 in modulating specific 
EMT pathways through regulation of SNAI1 expression. BRG1 also regulates the 
formation and organisation of the cytoskeleton which is vital to wound healing 
migration. However these data are primarily obtained from a keratinocyte based 2D 
migration model, as such it cannot truly explain the effects occurring during in vivo 
wound healing.
  
 
 
 
 
 
 
 
 
5. Conclusions 
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Multiple variations of the SWI/SNF complex are present in the different human hair 
follicle cells. 
SWI/SNF complex controls the balance of cell proliferation in the human hair follicle 
outer root sheath. 
BRG1 is upregulated in the hyper-proliferating and migrating epithelia in the 
cutaneous wound. 
SWI/SNF complex controls epidermal keratinocyte migration without effecting their 
proliferation and apoptosis during the skin wound healing. 
BRG1 acts predominantly as a transcription co-activator in the human epidermal 
keratinocytes during the skin wound healing. 
BRG1 controls the changes in transcription programmes associated with the 
epithelial cell cytoskeletal remodelling and skin mobility, but not cell adhesion during 
the skin wound healing. 
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6. Future Studies 
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6.1 Determining the role of SWI/SNF in regulating proliferation of 
the outer root sheath cells in whole human hair follicles 
This work highlighted a potential role for SWI/SNF in regulating proliferation, or 
possibly differentiation, in the outer root sheath of hair follicles. Using laser capture 
microdissection (LCM) to isolate the cells which showed a drastic increase in 
proliferation after BRG1 suppression and comparing them with control outer root 
sheath cells, using microarray transcriptome analysis or similar, would elucidate if 
they are losing their stem like properties or differentiating into something other than 
ORS keratinocytes as suggested. There has been some investigation into Brg1s 
role in murine hair follicle cycling, however this does not match with the current data 
seen in humans, but with current technologies human hair follicle cycling cannot be 
accurately observed to determine if the roles are similar. 
6.2 Determining direct or indirect targets of BRG1 suppression 
during keratinocyte migration. 
While many migration, inflammation and wound healing associated genes are 
shown to be regulated by BRG1, the question remains as to whether they are direct 
or indirect targets. Chromatin immuno-precipitation combined sequencing (ChIP-
seq), would adequately determine direct or indirect targets. This same technique 
could also be used to elucidate specific SWI/SNF complex composition with in sub 
population of hair follicle cells. 
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6.3 further investigate the role of BRG1 on cytoskeletal elements 
and immune cells. 
Multiple GO terms and associated genes identified with microarray transcriptome 
analysis indicate that BRG1 regulates cytoskeletal elements and various cytokines. 
As fibroblasts are both required for wound healing and able to migrate more freely 
than keratinocytes, an investigation in to the role of BRG1 within fibroblast migration 
would determine if the effect is truly due to an effect on cytoskeletal 
formation/synthesis, or if its unique to the keratinocytes undergoing EMT. 
Additionally this work has highlighted a potential role for BRG1 and SWI/SNF in 
regulating inflammation, an integral part to wound healing, which could suggest 
BRG1 has a much larger role in wound healing than modulation of keratinocyte 
migration. 
6.4 Overexpression of BRG1 in keratinocyte migration 
As these data all point to a loss of BRG1 resulting in a delay to keratinocyte 
migration, it can be assumed that the overexpression of BRG1 would have the 
opposite effect, speeding up keratinocyte migration, and so speeding up wound 
healing. However, given the abundance of data implicating BRG1 and the rest of the 
SWI/SNF complex in cancer, specifically in skin cancer/melanoma, it would be more 
effective to identify the mechanism at work and determine if there are safer 
pathways which can be exploited to obtain the same result. 
The first step would be to use a plasmid/viral vector to overexpress BRG1 in a cell 
culture model, and determine if it does have the desired effect of speeding up 
keratinocyte migration. 
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6.5 Recovery of phenotype using BRM. 
As previously stated, SWI/SNF has 2 mutually exclusive ATPase subunits, BRG1 
and BRM, as this study focused on BRG1 there is a possibility that BRM could be 
used to recover the negative effects. Alternatively a double knockdown of BRG1 and 
BRM may further excaudate the effect resulting in a more prominent delay, or 
potentially a full inhibition, of keratinocyte migration. A new chemical inhibitor has 
recently been developed, which is reportedly highly specific for SWI/SNF ATPase 
subunits and capable of inhibiting their function (Wu et al., 2019b).  
 
 
By combining these future studies a clear picture of the specific mechanisms at work 
could be obtained, which would determine if BRG1 could be exploited to 
enhance/speed up keratinocyte migration in a clinical aspect. As stated there is 
currently a strong link to SWI/SNF errors and cancer, which would need to be fully 
addressed before attempting to exploit BRG1 in an in vivo setting. While this may be 
a pipe dream, completion of these suggested future studies would go a long way 
towards determining if it will ever be feasible. 
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8.1 Enrichment of GO terms of genes after SMARAC4 siRNA 
treatment in 0 hours after scratching 
8.1.1 Enrichment of biological process related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 0 hours after scratching 
 
 188 
 
 
 189 
 
 
 190 
 
 
 191 
 
 
  
 192 
 
8.1.2 Enrichment of molecular function related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 0 hours after scratching 
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8.1.3 Enrichment of cellular components related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 0 hours after scratching 
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8.1.4 Enrichment of biological process related GO terms of upregulated genes 
after SMARAC4 siRNA treatment in 0 hours after scratching 
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8.1.5 Enrichment of molecular function related GO terms of upregulated genes 
after SMARAC4 siRNA treatment in 0 hours after scratching 
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8.1.6 Enrichment of cellular component related GO terms of upregulated 
genes after SMARAC4 siRNA treatment in 0 hours after scratching 
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8.2 Enrichment of GO terms of genes after SMARAC4 siRNA 
treatment in 24 hours after scratching 
8.2.1 Enrichment of biological process related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 24 hours after scratching 
 
 201 
 
 
 202 
 
 
  
 203 
 
8.2.2 Enrichment of molecular function related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 24 hours after scratching 
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8.2.3 Enrichment of cellular component related GO terms of downregulated 
genes after SMARAC4 siRNA treatment in 24 hours after scratching 
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8.2.4 Enrichment of biological process related GO terms of upregulated genes 
after SMARAC4 siRNA treatment in 24 hours after scratching 
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8.2.5 Enrichment of molecular function related GO terms of upregulated genes 
after SMARAC4 siRNA treatment in 24 hours after scratching 
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8.2.6 Enrichment of cellular component related GO terms of upregulated 
genes after SMARAC4 siRNA treatment in 24 hours after scratching 
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8.3 Enrichment of GO terms of genes after control siRNA 
treatment in 24 hours after scratching 
8.3.1 Enrichment of biological process related GO terms of downregulated 
genes after control siRNA treatment in 24 hours after scratching 
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8.3.2 Enrichment of molecular function related GO terms of downregulated 
genes after control siRNA treatment in 24 hours after scratching 
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8.3.3 Enrichment of cellular component related GO terms of downregulated 
genes after control siRNA treatment in 24 hours after scratching 
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8.3.4 Enrichment of biological process related GO terms of upregulated genes 
after control siRNA treatment in 24 hours after scratching 
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8.3.5 Enrichment of molecular function related GO terms of upregulated genes 
after control siRNA treatment in 24 hours after scratching 
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8.3.6 Enrichment of cellular component related GO terms of upregulated 
genes after control siRNA treatment in 24 hours after scratching 
 
 
